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Abstract 
 
 The insulin/IGF-1 signaling (IIS) was initially identified in C. elegans to control a developmental 
phenotype called dauer. Subsequently, it was realized that lifespan was extended by mutations in this 
pathway and became an intense focus of study. The IIS pathway regulates growth, metabolism and 
longevity across phylogeny and plays important roles in human disease such as cancer and diabetes. Given 
the large number of cellular processes that this pathway controls, understanding the regulatory 
mechanisms that modulate insulin/IGF-1 signaling is of paramount importance.  
IIS signaling is a very well-studied kinase cascade but few phosphatases in the pathway are known. 
Identification of these phosphatases, especially those that counteract the activity of the kinases, would 
provide a better insight into the regulation of this critical pathway. Study of serine/threonine phosphatases 
is hampered by the lack of appropriate reagents.  
In Chapter II, we discuss the design and results of an RNAi screen of serine/threonine phosphatases 
performed in C. elegans using dauer formation as a phenotypic output. We identified several strong 
regulators of dauer formation and in Chapter III, proceed to characterize one of the top candidates of our 
screen, pptr-1. We show that pptr-1 regulates the IIS and thereby affects lifespan, development and 
metabolism in C .elegans. 
pptr-1 gene encodes a protein with high homology to the mammalian B56 family of PP2A regulatory 
subunits. PP2A is a ubiquitously expressed phosphatase that is involved in multiple cellular processes 
whose specificity determined by its association with distinct regulatory subunits. 
Our studies using C. elegans provides mechanistic insight into how the PP2A regulatory subunit PPTR-1 
specifically modulates AKT-1 activity by regulating its phosphorylation status in the context of a whole 
organism. Furthermore, we show that this mechanism of regulation is conserved in mammals. 
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CHAPTER I 
A general introduction to aging and its study 
Introduction: 
Aging has been one of the most accepted but least understood processes in human life.  Aging can be 
defined as an inevitable decline in physiological functions over time affecting almost all organisms. Some of 
the universal features of aging include decrease in metabolic activity, decrease in the ability to reproduce 
and physiological deterioration of tissues(Browner, Kahn et al. 2004) (Figure 1). Every tissue, organ and 
organ-system becomes involved in this interminable process until the whole organism fails, resulting finally 
in the death of the individual(Leveille 2004; Volpi, Nazemi et al. 2004; Wolkow 2006). The physiological 
decline associated with aging results in increased incidence of age related diseases such as hypertension, 
diabetes, degenerative diseases like arthritis, stroke and dementia.   
Surprisingly some of the features of aging are remarkably similar in diverse species.  For instance, 
mitochondrial activity and metabolism has been shown to reduce as a function of age in humans and other 
model organisms like flies and worms(Ames 2004; Balaban, Nemoto et al. 2005). Aging C. elegans show 
muscle wasting, slow mobility and similar histological features of sarcopenia (muscle wasting) that are 
commonly seen in older individuals(Fisher 2004; Wolkow 2006).  
Aging is one of the foremost causes of disease and decline in our society. The risk of diabetes, 
cancer, cardio-vascular and other major diseases all increase with age. The top five morbidities that 
increase as a result of aging are cardiovascular disorders, dementia and nervous system disorders, 
musculoskeletal disorders, infectious diseases and neoplasia (Committee on a National Research Agenda on 
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Aging 1991). Improvements in health care over the past few decades have resulted in an expansion of the 
geriatric population and a concomitant increase in health-care needs. Over 50% of the health care budget is 
projected to be used for age-related disorders over the next decade and with a projected $3.4 trillion 
health budget by 2014 (S. Heffler; Rice and Fineman 2004; Gandjour 2009), the immensity of the problem is 
obvious. Therefore, an insight into the process of aging that helps to reduce/mitigate age related decline is 
bound to eventually translate into almost every field of modern medicine and science.  
Postulated mechanisms of Aging:  
 More than a dozen different theories have been put forward as probable causes of aging (causal) 
and all of these can be broadly classified into 2 main groups(Ricklefs 1998; Moorad and Promislow 2008; 
Ljubuncic and Reznick 2009). The basic tenet of the first group (Genetic theories of aging) is that aging is a 
genetically programmed parameter much like an extension of development and puberty. The second group 
(Wear and tear theories of aging) postulates that aging is a result of normal wear and tear of living, a result 
of both internal and environmental insults, as a byproduct of life-processes.  
Causal Theories of aging: 
Wear and Tear theories: 
Contrary to the genetic theories of aging, the proponents of the Damage (Wear and tear) group of 
theories contend that aging is a result of irreversible accumulation of damage over time that finally results 
in death. The most commonly used analogy is to that of an old car. After multiple repairs there reaches a 
point in the life of a car that multiple systems start to fail and it is no longer feasible to repair the vehicle 
anymore. Mathematicians have systematically studied and modeled the failing of mechanical devices, 
formally known as ‘Reliability Theory’. Surprisingly enough, the Weibull distribution that predicts  
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What is aging?
Progressive deterioration of 
cells, tissues, organs
AGING
Decreased fecundity and 
proliferative potential
An increased risk of 
injury and death
Adapted from Braechman et al. (2001) Mech. Ageing and Dev.
Decline of metabolic 
activity
 
Figure 1 
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mechanical failure rates can also accurately model mortality data of a population. The wear and tear 
theories implicate various sources of damage as the main reason for the aging process. 
The Oxidative damage or free radical theory  (Buffenstein, Edrey et al. 2008) was originally 
proposed by Herman in 1950 . Free radicals are highly reactive molecules generated as a byproduct of 
redox reactions in the cell. The major cellular source of free radicals is derived from oxygen and termed 
Reactive Oxygen Species (ROS).  ROS can react with cellular macromolecules such as DNA, RNA, protein and 
lipid resulting in damage and interference with their normal function (Figure 2). Free radical damage to 
DNA can result in cross-linking of DNA strands, base substitutions and deletions resulting in mutation and 
genomic instability. Amino acids in structural proteins and enzymes can undergo covalent modifications 
(for example, protein carbonylation) that interfere with normal function of the protein. Lipofuscin 
(intracellular aging pigment) is known to accumulate in lysosomes as a function of age and has been shown 
to be an indigestible byproduct of unsaturated fatty acid oxidation. In order to prevent such damage, 
cellular mechanisms exist that counteract and neutralize ROS. Enzymes such as catalase, superoxide 
dismutase and proteins like glutathione aid in scavenging free radicals before they damage cellular 
components. 
The oxidative damage theory has also resulted in several derivative theories of aging. Although ROS 
can be produced in diverse ways including ionizing radiation, peroxisomal fatty acid oxidation, and other 
cellular redox reactions, the major source of ROS is from the mitochondria as a byproduct of ATP 
production. This has resulted in the mitochondrial theory of aging and the related rate of living theories. 
Since the mitochondria are the seat of oxidative phosphorylation and consequently ROS production they 
are also the most affected by oxidative damage. Indeed, mitochondrial DNA damage has been documented 
  5 
 
to increase as a function of age. However, there has been no conclusive proof of mitochondrial damage in 
the causality of aging. 
Cellular damage in particular has been proposed to be an important determinant in the aging 
process. In order to maintain cellular homeostasis, damage response and repair pathways exist in the cell. 
DNA damage can be corrected by DNA repair enzymes and damaged proteins can be targeted to undergo 
recycling by protein degradation pathways. The mutation accumulation (DNA Damage) theory in particular 
posits that mutations in DNA accumulate as a function of time, until finally the damage exceeds the repair 
limits of the cell and results in a catastrophic failure and death. However, studies have shown that the 
mutation rates in old animals are not very different from those of young animals. Moreover, cells in old 
animals do not show a high enough level of mutations in order to justify the catastrophic mutation theory.  
As of now, there is no firm proof that DNA damage and mutation accumulation alone are responsible for 
the general aging seen in most organisms.  
Despite this view however, the role of DNA damage in specific cellular niches cannot be completely 
dismissed. Most tissues in mammals and other multicellular organisms are in a state of constant renewal 
from stem cells. Any damage in this small but important compartment of cells can have an impact in the 
overall health and state of the organism(Bellantuono and Keith 2007; Ljubuncic and Reznick 2009). This 
could especially be true in some of the inherited accelerated aging syndromes like Werner’s and 
Hutchinson-Gilford progeria (Oshima 2000; Bridger and Kill 2004; Lans and Hoeijmakers 2006). The affected 
individuals develop several phenotypes of accelerated aging including the appearance of cardiovascular 
diseases and failure to thrive resulting in a severely compromised lifespan.  One of the reasons for the 
accelerated aging phenotype in these accelerated aging syndromes is thought to be a result of selective 
depletion of stem-cell population as a result of increased DNA damage and mutational load(Brown 2003; 
Kaneko and Kondo 2004; Beausejour 2007; Bellantuono and Keith 2007).  
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(Buffenstein, Edrey et al. 2008) 
Figure 2
Oxidative damage as a cause of aging 
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The telomerase theory of aging, when it was proposed, seemed to be an elegant solution to the 
long standing quest to understand aging. Eukaryotic genome is organized into highly packaged linear 
chromosomes. DNA polymerases are unable to completely replicate the 3’ end of linear DNA and as a result 
with successive replications the ends of linear DNA will tend to be lost. The ends of linear chromosomes are 
therefore protected by repeats called telomeres. Telomeres are added to the ends by the enzyme 
telomerase. Interestingly, telomerase activity is only present in stem cells and transformed cancer cells but 
absent in somatic cells. Since somatic cells do not express telomeres, with each successive division they 
lose a small part of the telomere until they reach a point (Hayflick limit) when the telomeres are completely 
lost and DNA damage begins to occur and cells undergo senescence and stop dividing. The telomerase 
theory suggests that aging is because of successive shortening of telomeres with repeated cell divisions 
thereby eventually resulting in senescence. However, several studies have challenged the importance of 
telomerase in normal aging. Firstly, there was no significant difference in the replicative lifespan of 
fibroblasts derived from old or young individuals and secondly mouse studies have shown that telomerase 
knockouts did not show any difference in aging or lifespan compared to wild-type mice. These and other 
studies have therefore concluded that currently there is no clear-cut evidence that the length of telomeres 
has any correlation to normal aging processes and phenotypes. 
The rate of living theory suggests that every organism has a limited maximal aerobic potential 
which is determined by the mitochondrial capacity for oxidative phosphorylation. Studies in flies and 
worms have shown that the lifespan of these organisms are longer at a lower temperature, where in the 
oxygen consumption and rate of metabolism are reduced. Similarly, an inverse correlation has been 
observed between metabolic rate and lifespan in different species. Smaller mammals seem to have higher 
metabolic rates and shorter lifespans compared to larger mammals with longer lifespans. However, there 
are several exceptions to this general rule, for example, birds and bats have a much higher metabolism and 
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longer lifespan than similar sized rodents suggesting that the observed correlation between metabolic rate 
and longevity might be a result of independent evolutionary pressures on lifespan and metabolic rates. 
Genetic theories of aging:  
The phenotypic similarity of aging individuals within a species coupled with the species specific 
restriction of maximum lifespan lends credence to the idea that aging is probably an extension of 
development. The genetic/programmed theories were a subject of great controversy in the past but recent 
data from model organisms has renewed interest in them. In C. elegans, for example, mutations have been 
identified that extend the lifespan by almost 5 times the wild-type lifespan (Figure 3). Interestingly, most of 
the well studied genes that affect lifespan also affect the developmental cycle of C. elegans. 
  C elegans undergoes 4 larval molts L1 through L4 before becoming an adult in the presence of 
conducive environmental conditions. However, under adverse conditions like high temperature, 
overcrowding and starvation they enter an alternative larval stage (L2d) called dauer. Dauer formation is 
controlled by several distinct pathways of which the major pathway is insulin/IGF-1 signaling cascade.  
Mutations in certain components of insulin/IGF-1, a neuroendocrine signaling pathway, can result in 
increased mean and maximal lifespan. Data in worms suggest that signals from diverse tissues like sensory 
neurons, the gonad and the germline converge on the insulin/IGF-1 pathway to eventually modify the 
lifespan of the whole organism. Surprisingly, mutations that interfere with IGF1 signaling in mice also 
enhance longevity. For example, Ames dwarf mice have a mutation in Prop-1 that results in a defect in 
anterior pituitary differentiation. These mice have lower levels of circulating GH and IGF1 but live almost 
50% longer than wild-type mice(Barbieri, Bonafe et al. 2003; Holzenberger, Dupont et al. 2003). Exciting 
findings such as these have resulted in the resurgence of interest in role of genetics in aging. Current data  
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from worms, flies, mice and other animals indicate that aging can be modulated in these organisms by 
genetic manipulations. However, no gerontogene has been identified that can conclusively change the rate 
of aging and therefore no firm proof exists that aging is a strictly genetically regulated phenomenon. 
None of the afore-mentioned theories, can completely explain the current data we have from 
model organisms, epidemiological and evolutionary studies. Aging seems to be a multifaceted problem 
with genetic, environmental and stochastic components and no single theory of aging can completely 
explain all its features.  
 
Studying aging: 
Biomarkers: 
An important requirement in aging studies is to predict the rate of aging. Aging is inherently a 
stochastic process, but can be significantly modulated by genetic and non-genetic (dietary restriction) 
interventions(Austad 2001). Different individuals of the same chronological age in a population show 
significantly different physiological states necessitating a way to measure the physiological age of the 
individual. Also any intervention that increases lifespan significantly, probably, does so by delaying or 
slowing aging. A biomarker of aging must therefore be a direct indicator of physiological age. It must show 
a slower change or accumulation in treatments enhancing longevity and vice versa(McClearn 1997; Ingram, 
Nakamura et al. 2001). Identifying biomarkers of aging has an enormous potential for accelerating aging 
research since currently the only reliable indicator of aging is lifespan which is too tedious a parameter to 
follow and conduct elaborate experiments, more so in longer lived species.  Although an almost decade 
long effort has identified several surrogate markers of aging (glycoxidation of collagen, cell replication, 
immunological markers) none of them are accurate enough to be used as a biomarker of aging in humans 
or in most other higher mammals {(Butler, Sprott et al. 2004; Warner 2004) }.   
  11 
 
Lifespan/Mortality curves: 
The most accepted measure of aging is lifespan(L. Piantanelli 1992; Johnson 2006). The lifespan of a 
single individual is simply measured as the length of time that the individual is alive. When such data is 
collected for multiple individuals of a particular species and plotted over a period of time, we get a 
remarkably reproducible parameter – the species specific lifespan. Generally the word ‘Lifespan’ in 
literature refers to the species specific lifespan unless qualified otherwise.  In captive/laboratory/civilized 
conditions the slope of the lifespan curve is initially parallel to the x-axis where majority of the individuals 
are alive. This initial part of the curve can sometimes slope down more acutely in the presence of predation 
and disease (Figure 4).  The second part of the curve is marked by an exponential drop in survival (and an 
increase in mortality) followed by a third slow (linear) drop-off when only a few long lived individuals are 
left until finally all of the individuals are dead (L. Piantanelli 1992). There are several features of the lifespan 
curve worth mentioning: 
1) The overall shape of the lifespan curve of different species is similar (Figure 5) although the maximum 
lifespan of these species can differ by a factor of almost 103. This similarity in shape indicates a basic 
conservation of processes responsible for regulating longevity (or mortality) across phylogeny(Hughes and 
Reynolds 2005). 
2) Maximum (Species specific) lifespan is constant for a given species. For example, over the past 50,000 
years the maximum lifespan of humans has remained constant (Figure 4). But, the average lifespan (life 
expectancy) has improved significantly due to civilization and improvements in health-care as illustrated in 
Figure 4. The slope of the first part of the curve becomes more horizontal with decrease in age-
independent causes of mortality. However, the second component of age-dependent mortality and as a 
result maximum lifespan has not changed significantly. This restriction of maximum lifespan despite  
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increase in life expectancy indicates that processes responsible for regulating longevity is determined 
genetically.   Not surprisingly therefore, in model organisms genetic mutations have been identified that 
can extend the maximum lifespan by as much as five-times (Figure 3)(Arantes-Oliveira, Berman et al. 2003). 
3).Lifespan curve of a genetically isogenic population is indistinguishable from captive wild-type 
populations. As an example, lifespan curves of C. elegans (that can be propagated from a single 
hermaphrodite animal) and in-bred mouse lines still shows the same classical sigmoidal shape and age-
dependent mortality as wild-type animals. This indicates that despite the presence of a genetic restriction 
on maximum longevity for a species, individual lifespan is determined by other stochastic/environmental 
factors (Wolkow 2006).   
Model organisms for Aging studies: 
 One the most reliable and widely accepted parameter in the study of aging is lifespan. Lifespan has 
been shown to correlate well with aging process(Warner 2004). However, to measure lifespan it becomes 
necessary to follow a population till a significant end-point such as the mean (50% of individuals are dead) 
or maximum lifespan (all individuals of the population are dead) of that organism. Given the relatively long 
lifespan of humans it becomes necessary to use model organisms to study this process. Moreover, it is not 
possible to utilize systematic interventional studies for ethical and practical reasons in humans. Aging 
studies have therefore been done in model organisms to circumvent these problems. Studies have used 
unicellular organisms like yeast; invertebrate species like drosophila, C. elegans; and mammals such as 
mouse and monkeys(Kuningas, Mooijaart et al. 2008). The two key questions to be balanced with the use 
of model systems are:  
1) How well does the underlying mechanism of aging that is being studied correlate (similar) with 
Humans?  
2) How long (feasible) does it take for a study to determine if an intervention affects aging?  
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Feasibility is a direct correlation of several factors such as the time taken for the study, ease of 
maintaining the model organism and ease of the proposed intervention. Evolutionarily lower organisms are 
therefore more ‘feasible’ to study but evolutionarily closer organisms are more likely to have similar 
underlying mechanisms of aging compared to distant organisms. There are two potential solutions to this 
conundrum. First, is to utilize a surrogate of aging, such as biomarker, for studies in higher organisms, or 
second, use the more tenable models to systematically identify interventions/genes that regulate aging and 
then verify them in higher organisms. The latter approach has given many key insights into our current 
understanding of aging(Dufour and Larsson 2004).   
Table 1 shows a comparison of different phenotypes associated with age between different model 
organisms. Several key features of aging such as mitochondrial dysfunction, muscle-loss and general 
decrease in fitness are relatively well conserved among different model organisms. Such processes are 
likely to be a result of ‘universal’ or conserved ‘public mechanisms’ of aging and studying them may yield 
important insights into human aging and disease(Hekimi 2006). However, it is important to identify and 
account for key differences that exist by virtue of evolutionary divergence. For example, cancers are a 
major cause of age associated mortality and morbidity in humans but the model organism C. elegans is a 
post mitotic and therefore immune to neoplasia.  
C. elegans as a model organism for aging: 
 C. elegans has been used for over a decade to investigate the molecular mechanisms of aging. C. 
elegans has several inherent characteristics that make it an ideal model system. Powerful genetics 
(molecular and classical), small size, easy maintenance, transparency, well studied anatomical structure and 
complete sequence information with up-to-date annotation makes it an ideal system for investigating basic 
questions. However, apart from these general characteristics there are other compelling reasons for using 
it to study aging. A short lifespan of about 16 days at 25oC makes lifespan experiments feasible. Lifespan is 
demographically similar to outbred, higher organisms (Figure 5). C. elegans shows age related changes like 
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lipofuschin accumulation, sarcopenia and above all random and highly idiosyncratic decline in tissue 
function that is very similar to that seen in mammals (Gershon and Gershon 2002; Herndon, Schmeissner et 
al. 2002; Fisher 2004).  
It was predicted that metabolism and mitochondrial function were important determinants of 
metazoan lifespan. However, conclusive evidence came forth from C. elegans screens showing that 
reducing mitochondrial function (ETC – Electron Transport Chain) significantly extended lifespan (Sohal and 
Weindruch 1996; Feng, Bussiere et al. 2001; Lee, Lee et al. 2003). Similarly, much of our present 
understanding about the molecular mechanisms of aging comes from studying C. elegans. For example, the 
role of insulin-like signaling pathway in lifespan was initially identified in worms and later was confirmed in 
mammals (Kenyon, Chang et al. 1993; Brown-Borg, Borg et al. 1996; Henderson and Johnson 2001; Tu, 
Epstein et al. 2002; McCulloch and Gems 2003). In worms, knockout of daf-2 (the insulin-like receptor) 
doubles lifespan while knocking out daf-16 also, (a forkhead transcription factor) which is the final output 
of the pathway, abrogates the extension in lifespan (Gottlieb and Ruvkun 1994; Larsen, Albert et al. 1995; 
Ogg, Paradis et al. 1997). These among other studies have established C. elegans to be a viable system to 
study aging and still apply these findings to higher organisms.  
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Aging phenotypes in Model organisms. 
  
Table 1 
              (Vijg and Campisi 2008) 
Phenotype H. sapiens M. musculus D. melanogaster C. elegans 
Decreased cardiac function Yes Yes Yes NA 
Apoptosis, senescence (somatic cells) Yes Yes Yes ? 
Cancer, hyperplasia Yes Yes No No 
Genome instability Yes Yes Yes Yes 
Macromolecular aggregates Yes Yes Yes Yes 
Reduced memory and learning Yes Yes Yes NA 
Decline in GH, DHEA, testosterone, IGF Yes Yes ? ? 
Increase in gonadotropins, insulin Yes Yes ? ? 
Decreased thyroid function Yes Yes NA NA 
Decrease in innate immunity Yes Yes Yes Yes 
Increase in inflammation Yes Yes No No 
Skin/cuticle morphology changes Yes Yes ? Yes 
Decreased mitochondrial function Yes Yes Yes Yes 
Sarcopenia Yes Yes Yes Yes 
Osteoporosis Yes Yes NA NA 
Abnormal sleep/rest patterns Yes Yes Yes ? 
Decrease in vision Yes Yes ? NA 
Demyelination Yes Yes ? No 
Decreased fitness Yes Yes Yes Yes 
Arteriosclerosis Yes No NA NA 
Changes in fat Yes Yes ? ? 
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Insulin/IGF-1 signaling pathway in C. elegans: 
 
The insulin/IGF-1-like signaling (IIS) pathway is an evolutionarily highly conserved neuro-endocrine 
pathway that regulates multiple biological processes including metabolism, development, stress resistance 
and lifespan (Finch and Ruvkun 2001; Barbieri, Bonafe et al. 2003; Kenyon 2005; Wolff and Dillin 2006; 
Antebi 2007). Almost every component of the IIS pathway found in C. elegans has a homologue in 
mammals with a similar conserved function (Figure 6). However, keeping with the exponential increase in 
complexity up the evolutionary ladder this pathway has greatly expanded.  
In mammals there are two distinct pathways – the insulin pathway dedicated to metabolic/energy 
regulation and the IGF-1/2 pathway that regulates growth and survival.  The upstream components in 
humans include the 3 ligands (insulin, IGF-1 and IGF-2) and 3 receptors (Insulin receptor, type-1 and type-2) 
to which they bind. The insulin receptor is a heterotetramer consisting of two α and β subunits coupled by 
disulphide linkages. Ligand binding to the extra-cellular α subunits results in a conformational change that 
propagates to the transmembrane β -subunits and activates its intrinsic tyrosine kinase activity. Activation 
of tyrosine kinase activity then results in autophosphorylation of key residues in the intracellular domain 
and downstream targets (including the insulin receptor substrates –IRS proteins) that mediate downstream 
signaling from the receptor. Phosphorylation of IRS proteins then allow them to associate to SH2 domain 
containing proteins such as the PI3 Kinase regulatory subunit (activating PI3 Kinase pathway) and GRB2, 
SHP2 (activating ras/MAPK pathway) thus allowing signals to propagate to multiple downstream pathways. 
The PI3-Kinase pathway has been recognized to be an important component of the insulin/IGF-1 
signaling pathway and known to mediate glucose transport, glycogen storage, growth stimulation and 
survival. Activation of the PI3 Kinase in turn recruits PI3-dependent kinase (PDK1), a serine/threonine  
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kinase, which then in turn phosphorylates and activates other downstream serine/threonine kinases of the 
AGC-family (AKT1/2/3,SGK1, p70rsk and PKC), these in turn phosphorylate their substrates to regulate 
diverse responses such as growth, differentiation, glucose transport, angiogenesis and stress response 
(Barbieri, Bonafe et al. 2003; Giri, Mutalik et al. 2004; Leibiger and Berggren 2008; Salih and Brunet 2008).  
In C. elegans, the insulin-like receptor DAF-2 (Kimura, Tissenbaum et al. 1997)  signals through a PI 
3-kinase (AGE-1/AAP-1) (Morris, Tissenbaum et al. 1996; Wolkow, Munoz et al. 2002) signaling cascade that 
activates the downstream serine/threonine kinases PDK-1, AKT-1, AKT-2 and SGK-1 (Paradis and Ruvkun 
1998; Paradis, Ailion et al. 1999; Hertweck, Gobel et al. 2004).  These kinases in turn function to negatively 
regulate the forkhead transcription factor (FOXO), DAF-16 (Lin, Dorman et al. 1997; Ogg, Paradis et al. 
1997). Reduction-of-function mutations in serine/threonine kinases upstream of DAF-16 leads to changes 
in  lifespan, development, metabolism and/or stress resistance (Kenyon 2005; Wolff and Dillin 2006; Antebi 
2007).  Genetic studies in C. elegans showed that loss-of-function mutations in daf-16 completely 
suppresses these phenotypes (Kenyon 2005; Mukhopadhyay, Oh et al. 2006; Wolff and Dillin 2006; Antebi 
2007) implicating DAF-16 to be a major downstream target of the IIS pathway in worms.  
Serine/threonine phosphorylation of distinct sites in DAF-16 by AKT-1, AKT-2 and SGK-1 results in 
its nuclear exclusion and sequestration by 14-3-3 proteins in the cytosol (Lin, Hsin et al. 2001; Hertweck, 
Gobel et al. 2004).  In contrast, under low signaling conditions, DAF-16 is relieved of the inhibitory signals to 
enter the nucleus and regulate its target genes (Henderson and Johnson 2001; Lee, Hench et al. 2001; Lin, 
Hsin et al. 2001; Hertweck, Gobel et al. 2004; Oh, Mukhopadhyay et al. 2006). negative regulation of 
FOXO/DAF-16 by upstream kinases is conserved across species. Studies in mammals have shown that the 
mammalian AKT and SGK kinases can phosphorylate and negatively regulate FOXO (Brunet, Bonni et al. 
1999; Brunet, Datta et al. 2001; Brunet, Park et al. 2001; Calnan and Brunet 2008).   
In mammals FOXO has been extensively studied and known to play key roles in cell-cycle arrest, 
stress response, differentiation and metabolism. Some of well studied down-stream targets of FOXO family 
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members include mediators of stress resistance (MnSOD, Gadd45α)  (Salih and Brunet 2008), angiogenesis 
(Ang2,eNOS), Apoptosis (Bim, fas), metabolism (Ppargc1α, G6pc) and cell cycle arrest(p27Kip,p21Cip). These 
endogenous functions of FOXO protein make it a very important target in neoplasia. Mutations in PTEN in 
breast cancer cells act by sequestering FOXO3 cytosol and preventing its activity. Expression of active 
FOXO3 results in inhibition of tumor growth in-vivo(Carter and Brunet 2007). Such studies have established 
the importance of FOXO proteins as important downstream mediators of insulin/IGF-1 signaling in 
mammals. It is also thought that FOXO activity might also be important in mammalian longevity given the 
similarity in the classes of downstream targets(Barbieri, Bonafe et al. 2003; Amador-Noguez, Yagi et al. 
2004). However, it is not currently known which, if any, FOXO isoforms are required for the long-lived 
phenotype of IGF-1 signaling defective mice models (Barbieri, Bonafe et al. 2003; Holzenberger, Dupont et 
al. 2003).   
In worms, as described above, DAF-16 is known to be absolutely required for multiple phenotypes 
of insulin pathway mutants including lifespan extension. Multiple studies have been done to identify DAF-
16 targets, particularly those responsible for the lifespan extension in IIS mutants. More than a few 
hundred genes were identified with some of the major classes being antioxidant genes(sod-3, ctl-1), stress 
response (hsp-16, hsp-12.6), pathogen resistance (spp-1), metabolic (gei-7, pnk-1) and anti-toxicity (mtl-1).        
From these results it appears that DAF-16 regulates a large group of genes in concert to mediate its 
longevity, stress resistance and other phenotypes(Hsu, Murphy et al. 2003; Lee, Kennedy et al. 2003; 
Murphy, McCarroll et al. 2003; Jensen, Gallo et al. 2006; Oh, Mukhopadhyay et al. 2006). The potential 
implication of these studies is that to modulate organismal aging successfully interventions must target 
upstream regulators of IIS/DAF-16 to activate the endogenous longevity assurance programs. In this light, 
identifying regulatory components of IIS/DAF-16 are mission critical for not only unraveling the complexity 
of aging but also to allow intervention in this process. In addition, such regulators will also be important 
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drug targets for a multitude of human diseases such as diabetes, dementia and cancer wherein 
dysregulated insulin/IGF-1 signaling is implicated.  
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CHAPTER II 
RNAi Screen for serine/threonine phosphatases regulating the C. elegans 
insulin/IGF-1 signaling cascade 
Introduction : 
Regulation of Protein function: 
Living organisms need to regulate their internal processes in a concerted and meaningful fashion in 
order to survive in an ever changing world. In order to do so, proteins can be regulated at the level of 
transcription, translation and post-translation. In eukaryotes, one of the most common means of regulating 
protein function is by post-translational modifications (PTM). There are several known PTMs such as 
acetylation, alkylation, amidation, sulfation, glycosylation (addition of glucose/carbohydrate moiety), 
prenylation (addition of farnesyl or geranylgeranyl isoprenoids derived from cholesterol), glutamylation, 
phosphorylation, ubiqination (ubiquitin peptide) and sumolyation. Some PTMs like glycosylation (cell 
surface and secreted proteins) and glutamylation (clotting factors) are essential to the normal activity of 
the protein. Others can result in enhancing or attenuating activity (phosphorylations), membrane 
localization (prenylation), and even target proteins to degradation (ubiquination). PTMs are not only used 
for regulating the activity of proteins but also for transducing extracellular signals into the cell quickly and 
reliably to target specific internal processes. Recently it has been appreciated that the same residue can be 
subject to different PTMs. The classical example is the ‘Yin-Yang’ model of O-Glc-Nac (glycosylation) 
modification blocking a phosphorylation at the same phospo-acceptor residue. This in-effect causes one 
modification to block the effect of the other (‘Yin-Yang’ model) and in some cases can result in complex 
effects including completely different cellular responses(Slawson, Housley et al. 2006).   
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Figure 7 
A) Schematic of classical kinase / phosphatase reaction 
B) Schematic of a signaling module mediated by reversible phosporylation  
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Protein Phosphorylation: 
One of the most well known and well studied PTM is reversible protein phosphorylation. Protein 
phosphorylation is catalyzed by enzymes (kinases) that hydrolyze ATP and transfer the γ-Phosphate from 
ATP to specific residues in the protein substrate. The reverse hydrolysis of the phosphate moiety from the 
protein is catalyzed by hydrolases (phosphatases) that return the protein to its original state (Figure 7A).  
There are several advantages to using phosphorylation as a key PTM for the cell. Covalent addition of a 
phosphate to amino acid side chains is rapid (few milliseconds), easily reversible and as a corollary, very 
low cost to the cell. To illustrate, to synthesize a 100 aa protein the energy cost for the cell is around 400 
high-energy phosphates, however, the same protein can reversibly undergo 400 phosphorylation-
dephosphorylation reactions without any loss of activity. The popularity of phosphorylation is attested to 
by the fact that almost 3-5% of most eukaryotic genomes consist of kinases and phosphatases and nearly 
30% of cellular proteins are phospho-proteins.  
Although phosphorylation is a facile and simple modification, it can have profound effects on the 
function of the target protein. Addition of a phosphate group confers a net negative charge to the amino 
acid side chain to which it is added resulting in a variety of possible changes. For example, phosphorylation 
can trigger a change in the conformation of target proteins, modify activity of enzymes, regulate interacting 
partners, target intracellular localization, change the stability of the protein substrate and finally even 
transduce signals (examples: Figure 7B,Figure 8A).  
Phosphorylation is employed extensively in signaling cascades which transfer an extracellular signal 
into the cell to modify functions/processes within. In signaling cascades many of the substrates that are 
phosphorylated in response to external signals are themselves kinases which are in-turn capable of 
phosphorylating other protein kinases/substrates. This cascading arrangement of kinases permits signal 
amplification and transmission through the cell to the final intended target(s) (Figure 8B). 
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Figure 8 
A) Schematic of phosphorylation activating an enzyme. 
B) Schematic of successive kinases resulting in a signaling cascade.  
  27 
 
Generally, signaling cascades remain active as long as the phosphorylation events persist. For a meaningful 
regulation of cellular functions, the transmission of signals into the cell needs to shut off as soon as it is no 
longer needed. Phosphatases therefore become intrinsically important to counteract and terminate signals 
by dephosphorylation of the down-stream kinases (and their substrates) to return them to their normal 
state. Indeed mutations resulting in hyper-activated signaling of growth-factor pathways are implicated in a 
majority of cancers.  
Proteins can be phosphorylated on nine amino acids: serine, threonine, tyrosine, cysteine, lysine, 
aspartate, glutamate and histidine. However the predominant phosphorylation events mediated by 
eukaryotic kinases occur at serine, threonine and tyrosine residues in that order (Figure 9). Based on the 
phospho-acceptor amino-acid in the substrate, kinases can be broadly classified into 3 groups. The two 
major groups are tyrosine and serine/threonine kinases and smaller group of dual-specificity kinases (for 
example, MAPKK) that can phosphorylate all three residues. Phylogenetically, all kinases share the catalytic 
domain (eukaryotic protein kinase - ePK motif) indicating that most kinases evolved from a common 
ancestor(Manning, Whyte et al. 2002). In humans there are approximately 518 kinases accounting for 1.7 % 
of the genome. Of these, 90 are tyrosine kinases (PTKs) and majority of the rest are serine/threonine 
kinases.  
A short overview of protein phosphatases: 
Phylogenetically, phosphatase evolution appears to have been more divergent and can be 
structurally and mechanistically classified into three major families  (Tonks 2006; Moorhead, Trinkle-
Mulcahy et al. 2007) (Table 2). The three classes are the PTP (phospho tyrosine phosphatase), PPP/PPM 
(both mostly phospho serine/threonine phosphatases) and finally the recently classified aspartate based 
catalysis group (FCP/SCP/HAD) group of enzymes. 
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Distribution of the  Phosphate Group in  Phosphoproteins
P-Tyr (1.8%)
P-Thr (11.8%)
P-Ser (86.4%)
Modified from : EUROPHOSPHATASES 2003, Barcelona, Spain - Viktor Dombrádi  
Figure 9 
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 Phospho tyrosine Phosphatase family: 
 The PTP members are a diverse group of about 100 members in humans. The similar number of 
tyrosine kinases and PTPs in the human genome indicates that the complexity of these opposing groups of 
proteins is similar. All PTPs share the similar catalytic motif (CX5R) in their catalytic domains but have 
diverse functional domains and consequently different substrate specificities and affinities. Indeed, some 
family members of PTPs are now known to dephosphorylate carbohydrates, mRNA and 
phosphoinositides(Moorhead, De Wever et al. 2009). The diversity in domain composition among the PTPs 
indicate that they have evolutionarily incorporated catalytic and regulatory modules (mediating substrate 
specificity) into a single protein at the genomic level.  
There are three main classes of PTPs (Figure 10). The first Class is further subdivided into the two 
main groups - the classical group of pTyr specific phosphatases and the Dual specificity phosphatases 
(DSPs). While the classical group of PTPs usually only dephosphorylate pTyr, the DSP group of enzymes are 
more pleiotropic and structurally diverse. DSPs have been shown to dephosphorylate serine, threonine, 
tyrosine, lipids and even complex carbohydrates(Tonks 2006; Moorhead, De Wever et al. 2009). Some 
important examples include the tumor suppressor PTEN (Phospho-inositol tri-phosphate phosphatase), 
MKPs (MAPK phosphatases – serine/threonine and tyrosine residues) and KAP (CDK associated 
phosphatase). The class II and Class III enzymes are represented by CDC25 and LMPTP respectively (Low 
mol. wt. phospho tyrosine phosphatase) and are thought to have evolved from primitive bacterial 
enzymes.(Alonso 2004; Andersen 2004) 
The Classical tyrosine phosphatase members can functionally be further classified into two classes: 
the transmembrane receptor like proteins (R) and the non-transmembrane/cytosolic PTPs (NR). The R-PTPs 
regulate signaling upon ligand binding by dephosphorylation of protein pTyr in contrast to  
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Figure 10 
Classification of PTPs and complexity of their domain architecture  
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the well known receptor tyrosine kinases. The R-PTPs have been implicated in cell-cell contact, adhesion 
mediated signaling (CAMs) and also in matrix-cellular interactions. The NR-PTPs are cytosolic and contain 
the catalytic domain and associated specific regulatory domains that mediate substrate specific 
dephosphorylation. For example, SH2 domain-containing protein tyrosine phosphatase-2 (SHP2) is targeted 
to pTyr motifs by the SH2 domain and is involved in regulating ras/MAPK pathways upon growth factor 
signaling. (Neel, Gu et al. 2003; Salmond and Alexander 2006)  
PPP/PPM families of Serine/threonine phosphatases: 
In contrast to PTPs, the number of Serine/threonine phosphatases (PSTP) in the human genome is 
vastly smaller than the corresponding number of S/T Kinases. In humans, for example, there are more than 
400 S/T kinases but only about 40 PSTPs(Barford D 1998; Cohen 2004; Moorhead, De Wever et al. 2009). 
Considered with the fact that more than 98% of the phospho proteins are modified at serine/threonine 
residues the question arises – how do such a small set of serine/threonine phosphatases regulate the great 
variety of substrates in an orderly and regulated fashion? The answer to this lies in the fact that most 
serine-threonine phosphatases are designed to function in a modular fashion. The phosphatase catalytic 
subunits associate with other proteins in the cell (regulatory proteins) which can then specify the 
appropriate substrate for the phosphatase. Indeed, numerous studies have shown that in-vivo, these 
phosphatases show exquisite specificity to substrates but in-vitro, and in the absence of the regulatory 
subunits, display promiscuous dephosphorylation towards substrates(Barford D 1998; Cohen 2004; 
Moorhead, De Wever et al. 2009).  
PSTPs consist of the two distinct families: the PPP and PPM family of enzymes, based on sequence 
similarity. Initially, before sequence information was known, the key difference upon which they were 
grouped was based on the requirement of exogenous divalent metal ions (especially Mg2+ or Mn2+) for the 
activity of PPM members and absence of such a requirement among PPP members. It is now known that 
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although the PPP and PPM families have dissimilar sequence, the structure and mechanism of catalysis are 
exceedingly similar and one of the classical examples of convergent evolution. 
PPP Family: 
The PPP family of enzymes contributes to the major portion of serine/threonine phosphatase 
activity present in cells both because of large number of members in this family and also the high levels of 
expression in the cell. All members of the PPP group of enzymes share a common catalytic core domain of 
~280 amino acids that are highly conserved across phyla. Indeed, some members of the PPP family such as 
PP1 and PP2A have sequence similarity approaching nearly 97% between humans and C. elegans.PPP 
members are among some of the most highly conserved proteins in evolution(Kennelly 2001).  
The PPP family commonly contains atleast 7 classes of phosphatases, PP1 - 7 (Table 2) and  a few 
more idiosyncratic atypical members in some species such as S. cerevisiae(Cohen 1997). As discussed 
above, most of the PPP family members utilize a modular design to achieve substrate specificity and 
fidelity. Regulatory subunits have been reported for almost every member of the PPP family with the 
exception of PP5 and PP7 (Andreeva and Kutuzov 1999). The PP5 is peculiar in that, apart from the core 
catalytic domain it also has additional (TPR) regulatory domains as part of the same protein that modulates 
its activity(Moorhead, Trinkle-Mulcahy et al. 2007; Moorhead, De Wever et al. 2009).  
The PP1 (PPP1) family of enzymes is one of the most well known and well studied members of the 
PPP family. In humans, there are 3 members of the PP1 family (α,β/δ,γ) which are highly homologous to 
each other. In C. elegans, there exists 3 PP1 members of high similarity but this family has further expanded 
and there are an additional 40 PP1-like enzymes, with moderate sequence similarity to the PP1 catalytic 
subunit, whose functions are currently unknown. PP1 phosphatases are among the most versatile group of 
enzymes acting on diverse substrates such as glycogen, myosin, cell cycle kinases and other protein 
substrates. PP1 enzymes are modular and substrate targeting is performed by regulatory subunits. By 
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sequence analysis of known PP1 regulatory ‘subunits’ it was identified that the PP1 catalytic subunit is 
recruited using a relatively small docking motif, the RVXF/W motif. To date more than a 100 PP1 regulatory 
subunits have been described which mediate diverse functions from glycogen breakdown, cell-cycle 
progression, translational regulation and muscle contraction(Llorian, Beullens et al. 2004; Guergnon, 
Dessauge et al. 2006; Kwiek, Thacker et al. 2006; Pasder, Shpungin et al. 2006; Trinkle-Mulcahy 2006). 
The PP2A (PPP2) phosphatase functions in the cell as a heterotrimeric modular enzyme. In contrast 
to PP1 subunits, which are quite variable, PP2A subunits are more easily recognized owing to sequence and 
structural similarities of different groups. The PP2A heterotrimeric holoenzmye consists of a structural 
subunit (A), the catalytic subunit (C) and a variable regulatory subunit (C) which determines the substrate 
specificity, sub-cellular localization and activity of the enzyme complex. In addition to association with 
regulatory subunits PP2A is also subject to post-translational modifications (C-terminal methylation and 
phosphorylation) that regulate its activity (Van Hoof and Goris 2004; Prickett and Brautigan 2006; Yoo, 
Boylan et al. 2007; Eichhorn, Creyghton et al. 2008; Janssens, Longin et al. 2008; Yan, Lavin et al. 2008; Shi 
2009). Furthermore, some of the B-subunits themselves are subject to phosphorylation that might 
modulate their association/localization with the PP2A A-C core dimer and therefore regulate the 
holoenzmye activity. Humans have 2 Phosphatase catalytic subunits (PPPα ,β), 2 structural (A) subunits 
(PR65 α,β) and atleast 16 members in separate families of regulatory (B) subunits (B55, B56, B72 and 
striatin). The C. elegans genome contains a single catalytic (C) and structural subunits (A) and 7 regulatory 
subunits (B). 
 PP2A is known to be involved in the regulation of metabolism, mitosis, cell survival, and variety of 
other essential cellular processes but its function as a potential tumor suppressor has garnered the most 
attention. Mutations in the structural subunit that interferes with the binding of catalytic or regulatory 
subunits have been linked to several tumors(Xu, Xing et al. 2006). Similarly, N-terminal deletions of B56 
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subunits were shown to be correlated with higher metastatic potential in melanomas and complete loss of 
B56 subunits were seen in lung-cancer cell lines. Re-expression of the B56γ subunit in these cells resulted in 
a partial reversal of the cancer phenotype. Many natural tumorigenic toxins and viruses target the PP2A 
enzyme. For instance, the SV40 small T-antigen associates with the PP2A core dimer by mimicking a B-type 
regulatory subunit. It was shown that this interaction reduced the PP2A activity and thereby brought about 
cellular transformation. Indeed knocking down B56γ was sufficient to replicate the tumorigenic effects of 
SV40 small T-antigen(Chen, Possemato et al. 2004; Van Hoof and Goris 2004). The marine toxin, Okadaic 
acid, also effects its tumor promoting activities by reducing PP2A activity.   The PP4 and PP6 are closely 
related structurally and functionally to PP2A. They both utilize regulatory subunits to target their 
substrates.  
PP2B (PPP3) or calcineurin is a heterodimeric enzyme composed of a catalytic and a regulatory 
subunit (calmodulin-related). PP2B has an autoinhibitory C-terminal sequence that upon binding calcium 
moves away from the active site and stimulates activity of the enzyme. PP2B/calcineurin is best known for 
their action in T-cell response where they activate NFATc by dephosphorylation. Active NFATc is required 
for T-cell maturation and therefore PP2B inhibitors like cyclosporine and tacrolimus are used clinically as 
immunosuppressants. PP2B activity has also been appreciated to be important in memory formation and 
beta cell function(Yamashita, Katsumata et al. 2000; Heit 2007). The PPP5 and PPP7 are functionally similar 
in that they both have regulatory domains incorporated near the catalytic domains (EF-hands for PPP7 and 
TPR-repeats for PPP5). Similar to PP2B, the repeats have auto-inhibitory function and allow activation of 
the enzyme only when certain conditions are met (protein interactions in the case of PPP5 and Calcium for 
PPP7)(Yang 2005). PPP5 is known to be nuclear and its activity might be important for DNA repair 
mechanisms, glucocorticoid and stress signaling pathways.  
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Classes and functions of Human protein phosphatases
 
Table 2 
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PPM family: 
 
 The PPM family members were distinguished initially by their requirement for exogenous divalent 
cations (Mg2+, Mn2+) and insensitivity to classical phosphatase inhibitors like Okadaic acid and Calyculin 
A(Bellinzoni, Wehenkel et al. 2007; Wehenkel, Bellinzoni et al. 2007) but sensitive to metal chelators like 
EDTA. Compared to the PPP family members the PPM members show more structural diversity. The N-
terminal catalytic domain is similar in these enzymes but the C-terminal sequences are divergent which 
probably are responsible for the diverse array of functions by the PPM members. In contrast to the PPP 
family members, which usually recruit regulatory proteins, the PPM family of phosphatases generally acts 
as monomers.   
In Humans there are atleast 18 members of this family including the metabolic enzyme Pyruvate 
dehydrogenase phosphatase (PDP) and PHLPP domain phosphatases(Lu and Wang 2008). The PP2C family 
members have also been known to function in regulation of the ras/MAPK pathway and TGFβ signaling 
(Chen, Shen et al. 2006). In addition, the PHLPP and PP2C isoforms were shown to directly regulate insulin/ 
IGF-1 growth factor signaling, DNA-damage response and apoptosis (Lu and Wang 2008).  
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Screen for Serine/threonine phosphatases modulating IIS: 
 
Downstream of the Insulin/IGF-1 receptor the vast majority of the signaling occurs by regulatory 
modifications at serine/threonine residues. Consequently, regulation of the IIS pathway by 
serine/threonine protein kinases has been extensively studied. Serine/threonine phosphatases are 
important regulators for reverse reaction and to restore the original status of proteins. Phosphorylation can 
be either activating or inactivating depending on the context in the protein. For example, specific 
serine/threonine phosphorylations in the activation domain of kinases such as PDK1, AKT1/2/3 and SGK 
results in increased signaling activity in the cascade. However, S/T phosphorylation at specific sites in IRS 
proteins can negatively regulate signaling by making them poor substrates to the insulin receptor(Gual, Le 
Marchand-Brustel et al. 2005; Sun and Liu 2009). Similarly, FOXO can undergo both activation (JNK,MST1) 
and repression (AKT/SGK) by phosphorylation. (Wang, Bohmann et al. 2003; Oh, Mukhopadhyay et al. 
2005; Lehtinen, Yuan et al. 2006) 
In C. elegans, the lipid phosphatase DAF-18 (homologous to mammalian Phosphatase and Tensin 
Homolog, PTEN), was the only phosphatase known to function in the IIS pathway (Ogg and Ruvkun 1998; 
Gil, Malone Link et al. 1999; Mihaylova, Borland et al. 1999; Rouault, Kuwabara et al. 1999). However, little 
was known about the identity of protein serine/threonine phosphatases that regulate IIS pathway in C. 
elegans. To this end we performed a directed RNAi screen of serine/threonine protein phosphatases 
(PPP/PPM families) that affect phenotypes regulated by the IIS pathway.  
C. elegans development proceeds from an egg, through 4 larval stages into a self-fertilizing, 
hermaphrodite adult.  However, under unfavorable growth conditions such as crowding and low food 
availability worms at L1/2 stage can enter a stage of diapause known as dauer (Riddle D. 1997)(Figure 11A). 
The dauer stage is characterized by increased resistance to adverse environmental conditions and allows 
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the worms to survive until the return of favorable growth conditions, when eventually; they can resume 
development to form into reproductive adults. Genetic screens to identify genes mediating dauer 
formation have resulted in the identification of several pathways that control dauer diapauses (Figure 11B).  
Two main parallel signaling cascades, the TGFβ and the IIS pathways, were found to regulate dauer 
by eventually converging on daf-12 (steroid nuclear hormone receptor). The TGFβ pathway consists of daf-
7 (TGFβ ligand), daf-1, 4 (type I and II receptors), daf-8, 14, 3 (SMADS) and daf-5 (Sno/ski). Mutations in 
daf-7, 1, 4, 8, 14 are daf-c and suppressed by mutations in daf-3 and 5. However, daf-3 and 5 mutations 
cannot suppress IIS mutants.  
The other major parallel pathway to control dauer formation is the IIS pathway. Of the IIS 
components described previously, null mutations in daf-2, age-1, pdk-1 or both akt1;akt-2  results in a 
constitutive dauer phenotype that can be completely  suppressed by daf-16. It has been previously 
reported that loss of function mutations of daf-16 cannot suppress TGFβ daf-c mutations (such as daf-7), 
however, such experiments used point mutants of daf-16 (m26, m27) and may not be valid. Most daf-c 
mutations in both IIS and TGFβ pathways can be suppressed by the daf-d mutation in daf-12 indicating that 
both these pathways converge on daf-12 for dauer formation(Albert and Riddle 1988; Riddle and Albert 
1997).However, certain exceptions exist, certain strong alleles of daf-2 (including e1370) are not 
suppressed by daf-12 (lf) mutations and result in embryonic  or intermediate larval arrest but these alleles 
are completely suppressed by daf-16 (lf). These findings indicate that, in at least these alleles, DAF-16 and 
DAF-12 mediate dauer formation in a parallel but antagonistic fashion. DAF-16 activity precludes the 
developmental progression but the absence of DAF-12 prevents dauer formation thereby arresting the 
larvae in an intermediate stage.   
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Pathways regulating dauer formation in C. elegans
A
B
 
Figure 11 
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In order to identify phosphatases that regulate the IIS cascade in C. elegans we designed an RNAi 
modifier screen for dauer formation in daf-2(e1370) mutants. daf-2(e1370) is a temperature sensitive 
allele(Riddle, Swanson et al. 1981) and displays relatively normal growth (and no dauer formation) at 15o C 
but arrests as 100% dauers at 25oC(Kimura, Tissenbaum et al. 1997). In order to conduct the phosphatase 
RNAi screen, we decided to use an intermediate temperature of 20oC for several reasons. Firstly, at 20oC, 
partial signaling still exists in the pathway and it becomes possible to assay for both enhancers and 
suppressors of dauer formation. Serine/threonine phosphorylation is known to both activate and reduce 
signaling in the IIS pathway and therefore this strategy yielded candidates that both positively (increases 
dauer) and negatively (decreases dauer) regulate the IIS cascade upon RNAi knockdown. Secondly, since 
RNAi knockdown cannot usually mimic a complete loss of function it was necessary to use an intermediate 
temperature to increase the sensitivity of the screen. 
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Identifying candidate phosphatases for RNAi screen
In-Silico identification of Ser/Thr phosphatases of PPP and PPM families in the             
C. elegans genome (KOGs, Interpro, GO and BLAST)
60 Genes with Phosphatase activity
46 in Ahringer library, rest cloned (3 not cloned) + 6 PP2A 
regulatory subunits
daf-2(e1370) grown on RNAi bacteria at 15oC for 2 
generations
Pick 100-120 eggs into three separate 
plates at 20oC
Score for dauers after 3.5-4 days. 
Schematic of RNAi screen
A
B
 
Figure 12 
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Results and Discussion 
 
RNAi screen to identify phosphatases in IIS pathway 
 To identify the serine/threonine phosphatases in the C. elegans genome, we performed in silico 
analyses using both NCBI KOGs (clusters of euKaryotic Orthologous Groups) and WormBase (a C. elegans 
database: http://www.wormbase.org; WS152) annotations (Figure 12A). A total of 60 genes were identified 
for further analysis. We obtained RNAi clones for these phosphatases from the Ahringer RNAi library 
(Kamath and Ahringer 2003; Kamath, Fraser et al. 2003), generated them using available clones from the 
ORFeome library (Reboul, Vaglio et al. 2003) or cloned them de-novo using Gateway Technology 
(Invitrogen, USA; see Materials and Methods).  We were unable to clone 3 of the phosphatase cDNAs and 
therefore screened a total of 57 candidates (Table 3).  
 In addition, we included 6 of the 7 annotated PP2A holoenzyme regulatory subunits (one was not 
cloned) in the screen for two reasons.  First, a preliminary chemical inhibitor screen identified the PP2A 
family of phosphatases as important regulators of DAF-16 nuclear translocation (Padmanabhan and 
Tissenbaum, unpublished data).  Second, RNAi of the catalytic (C) and structural (A) subunits of PP2A 
resulted in lethality (data not shown). 
For the screen, daf-2(e1370) mutants were grown on RNAi-expressing bacteria for two generations, 
and eggs were picked onto 3 plates for each RNAi clone (Figure 12B). The plates were incubated at 20oC and 
scored 3.5-4 days later for the presence of dauers and non-dauers.  Since DAF-18 is the only known 
phosphatase that negatively regulates the IIS in C. elegans, we used daf-18 RNAi as a positive control in all 
our experiments.  
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C. elegans Serine/Threonine phosphatase members of PPP, PPM family and PP2A regulatory 
subunits selected for RNAi screen 
 
 
 
 
Table 3 
 
 
Phosphatase 
family
Members
C. elegans
homologs
PP2C 10
PPM
PDP 1
PP1 3
PP2A 1
PP4 2
PP5 1
PP6 1
PPP
PP1 like 40
B55/PR55 1
B56/PR61 2
PP2A regulatory 
subunits
B72/PR72 4
PP2B 1
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In order to compare potential candidates between successive experiments, percentage of dauers 
for a candidate was first calculated and then normalized by subtracting with the percent dauers in vector 
RNAi. This resulted in vector dauer% in each experiment to become zero and candidates that enhance 
dauer formation to have positive values and conversely candidates that suppress dauer to have negative 
values (Non-normalized numbers are also shown - Table 5). A cut-off value of 50% (2 fold) was chosen for 
both dauer suppressing and dauer enhancing candidates.  
 From a total of 63 RNAi clones (57 phosphatases and 6 PP2A regulatory subunits), we identified 4 
phosphatases that decreased daf-2(e1370) dauer formation to a level s less than 50% of Vector RNAi and 
16 phosphatases that increased daf-2(e1370) dauer formation to a level s more than 50% of Vector 
RNAi.(Table 4) 
 
Candidates suppressing dauer formation:  
 Genes that reduced dauer formation in the daf-2(e1370) mutants, upon knockdown, were putative 
negative regulators of IIS (Table 4A). The small number of genes (4) that showed the dauer suppression 
phenotype indicated that this was likely a specific effect. Moreover, previous genetic studies, have 
consistently identified only components of IIS as suppressors of dauer formation in daf-2(e1370).  
daf-2 (lf) alleles can be classified into 2 main classes based on phenotypic pleiotropy and location of the 
mutation. In general, Class I alleles are a result of mutation in the ligand binding domain and show daf-c, 
age (lifespan increase) and thermotolerance phenotypes. Class II alleles show additional phenotypes apart 
from Class I like, embryonic, L1 arrest, slow movement, reduced brood size and high incidence of internal 
hatching all of which are suppressible by daf-16. 
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daf-2(e1370) worms, a class II allele, also has defects such as slow growth (apparent even at 15oC), small 
brood size, internal hatching, stress-resistance and lifespan. Although all of these phenotypes are 
dependent on daf-16, it was possible that some phosphatases regulate only certain aspects of IIS and 
therefore affect only a subset of these phenotypes. Therefore, any apparent effects on other phenotypes 
like growth, brood size and internal hatching were also noted when appropriate.  
A secondary screen was conducted with another daf-2(e1368) (Class I) allele to verify that the suppression 
of dauer formation was class independent.  Candidates were further characterized in varying details as 
discussed below.     
fem-2: 
Our top candidate, fem-2 (T19C3.4) is a PP2C phosphatase known to function in C. elegans sex 
determination (Pilgrim, McGregor et al. 1995; Hansen and Pilgrim 1998). The secondary screen with daf-
2(e1368) revealed that fem-2 could not suppress the dauer formation in this strain. This indicated that fem-
2 activity was specifically affecting daf-2 dauer phenotype in a class II dependent manner. fem-2 RNAi 
resulted in DAF-16::GFP being more cytosolic in a daf-2(e1370);daf-16::gfp strain (observation). The human 
homologue of fem-2, hFem-2 has been previously identified as a Ca2+/Calmodulin dependent protein kinase 
phosphatase (CaMPKPase)(Tan, Chan et al. 2001). Moreover they also show that hFem-1 and C. elegans 
FEM-2 can mediate apoptosis in a caspase dependent manner. This effect was specific to FEM-2/hFem-2 
and other PP2C enzymes did not cause apoptosis. CaMPKinases are activated by phosphorylation and 
known to play important role in survival following ischemic insults. This study however, did not attempt to 
investigate in detail the pathway responsible for fem-2 over expression leading to apoptosis. IGF-1 signaling 
is known to promote survival and prevent caspase dependent cell death and it is possible that fem-2 
regulates the IIS cascade in a cell autonomous manner by fem-2 acting as a negative regulator in the IIS 
pathway through CAMPKinase. 
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  Alternatively, CaMPK has also been shown to be important in insulin stimulated glucose transport 
probably at the level of vesicle trafficking. Inhibition of CAMPK results in reduction of insulin activated 
transport by more than 80%(Konstantopoulos, Marcuccio et al. 2007). Recent analysis of daf-2(e1370) and 
comparison with known mutations in the mammalian Insulin receptor indicates that insulin activated 
signaling through certain alleles of daf-2 such as e1370 and sa223 can be overcome by using larger 
amounts of insulin(Patel, Garza-Garcia et al. 2008). Taken together with the known function of CAMPKinase 
in vesicle trafficking, fem-2 RNAi could increase CAMPKinase activity resulting in an increase in the released 
quanta of insulin-like ligands in C. elegans. This in turn could result in suppression of dauer formation by 
reactivating IIS signaling in a cell non-autonomous manner. This mechanism would predict that fem-2 RNAi 
mediated dauer suppression will be lost in daf-2 alleles with mutations in the ligand binding domain (for 
example,e1368) which agrees with the observed data. This hypothesis could be potentially tested by 
making daf-2 double mutants with the C. elegans  CAMPKinase homologue, unc-43 and performing RNAi 
epistasis experiments for fem-2 mediated dauer suppression.  
 pptr-1/PP2A regulatory subunits: 
 The next dauer suppressor of daf-2(e1370) dauer in the screen was the B56 homologue, pptr-1. 
pptr-1 RNAi suppressed the daf-2(e1368) strain equally well. An in-silico analysis of potential interactions 
using the tools developed by Zhong et al.(Zhong and Sternberg 2006) identified akt-2 as a predicted 
interaction partner extrapolated from data available in Drosophila Yeast 2 hybrid experiments. Zhong et al. 
used a novel method to identify functional interactors of any given gene by collectively utilizing 
interactome, expression, phenotype and functional annotation from C. elegans, S. cerevisiae and D. 
melanogaster. We found their method remarkably accurate for recapitulating known interactors. 
Subsequent genetic and biochemical characterization of this candidate revealed PPTR-1 to be responsible 
for dephosphorylating AKT-1 at the Thr-350 (PDK-1) site. (Please see the next chapter for a more detailed 
characterization of pptr-1.) 
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 ZK973.3/Pyruvate dehydrogenase phosphatase(PDP): 
 The third candidate that suppressed dauer formation was ZK973.3/PDP (a PP2C family member). 
PDP has a known metabolic function in dephosphorylating and activating pyruvate dehydrogenase complex 
(PDC). PDC is a large multimeric mitochondrial matrix enzyme that is responsible for converting pyruvate to 
acetyl-CoA which is then oxidized in the mitochondria for ATP production. PDC is phosphorylated by the 
pyruvate dehydrogenase kinase (inhibitory) and activated after dephosphorylation by PDP. Although PDC is 
exclusively mitochondrial, PDP is also found in the cytosol and nucleus. PDP was recently shown to 
dephosphorylate SMAD in the TGFβ pathway(Chen, Shen et al. 2006). Further analysis of this gene showed 
that PDP RNAi can suppress daf-2(e1368), daf-2(e1370);akt-1(ok535) dauers and daf-2(e1370) lifespan and 
heat-stress (data not shown). These findings indicate that PDP RNAi can modulate most aspects of IIS. 
Further study of this gene is being carried out by another graduate student in our lab. 
 
Candidates enhancing dauer formation: 
 Genes that enhance dauer formation in the daf-2(e1370) mutants, upon knockdown, are putative 
positive regulators of IIS (Table 4B). The results of the screen show a relatively large number of genes (16) 
showing significant enhancement of dauer formation which is not surprising given the complex nature of 
inputs into the dauer decision pathway. Known inputs into the dauer pathway are pheromone, 
temperature, food-signals and probably metabolic signals. Sensory neurons integrate environmental signals 
with internal cues to decide commitment to dauer formation. Candidates that enhance dauer formation 
upon knockdown could potentially act through several mechanisms. 
First, they could act directly as a component in the IIS pathway. Second, act synergistically with other dauer 
formation pathways such as the TGFβ, daf-11, and steroid receptor pathways. And lastly, could be a non-
specific reason of general slowing in development /growth (gro) as a result of knocking down an essential 
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gene. Furthermore, daf-2 (e1370) and other mutations in the IIS pathway can themselves result in a gro 
phenotype in a daf-16 dependent manner. The delay in development could potentially be misinterpreted 
as an increase in dauer formation because all plates were scored at the same time point. Usually all genes 
were subject to two generations of RNAi, unless it resulted in lethality or severe growth defects, to 
maximize knockdown and this usually resulted in uncovering of a gro phenotype. We do not find a 
consistent correlation between genes exhibiting gro/lethality and genes increasing dauer formation. For 
example, RNAi of W09C3.6, sur-6 resulted in gro/embryonic lethal phenotypes but did not show dauer 
enhancement phenotypes. In contrast, the top dauer enhancing genes like gsp-1, tax-6 showed gro 
phenotypes but were associated with more dramatic dauer enhancement.  
  Further characterization of this set of candidates was not done in this study. However, two 
candidates that enhance dauer formation have already been reported to act in the c. elegans IIS pathway 
from previous studies. tax-6, a gene encoding the calcineurin (PP2B) phosphatase, has been previously 
described to be important in mediating thermo and chemotaxis in worms(Kuhara, Inada et al. 2002). 
Sensory input is a major input into dauer formation and defective sensory perception could possibly 
enhance dauer formation in a cell non-autonomous way.      Recently, however,  tax-6 (Dong, Venable et al. 
2007) was identified on a large scale proteomic study as an important mediator and regulator of IIS in 
worms. tax-6 is expressed in multiple cell types including neurons and the intestine. Similar to our results 
Dong et al. found that inhibiting tax-6 increases dauer formation and extends lifespan of daf-2 mutants in a 
daf-16 dependent manner. In addition, Lara-Pezzi, Winn et al have shown that a mammalian homologue 
and calcineurin variant, CnAβ, to inhibit foxo activity and promote muscle regeneration in mice. They also 
showed that phosphorylation of upstream kinases, such as PDK1 and AKT1 were compromised upon knock 
down of CnAβ (Lara-Pezzi, Winn et al. 2007). These findings indicate that the tax-6 mediated regulation of 
IIS pathway may be conserved in worms and mammals. 
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Another candidate, F25D1.1 (PP2C), has been previously identified in two independent studies to 
be important in daf-16 mediated phenotypes (Wang and Kim 2003; Szewczyk, Udranszky et al. 2006). Wang 
et al. indentified F25D1.1 from microarray analysis of genes involved in dauer formation. They found that 
F25D1.1 levels were significantly downregulated in dauer larvae. In another independent transcriptome 
analysis, Szewczyk et al. identified F25D1.1 in the search of genes mediating lifespan and developmental 
delay in C.elegans maintenance medium (CeMM-a chemically defined liquid medium). Worms grown in 
CeMM show several phenotypes such as developmental delay and lifespan extension. They show that these 
phenotypes are a result of increased levels of daf-16 expression. Under low signaling conditions DAF-16 is 
de-repressed from upstream signaling, allowing it to translocate into the nucleus and transactivate or 
repress downstream targets. Both studies show significant down regulation of F25D1.1 upon activation of 
DAF-16 and this taken together with our findings of enhanced dauer formation in the daf-2(e1370) mutant, 
suggests that F25D1.1 could be a potentially important downstream component of IIS/daf-16 signaling. It 
would be interesting to identify if knocking down F25D1.1 can bypass the requirement of DAF-16 for daf-16 
dependent phenotypes. It is also possible that normal levels of F25D1.1 negatively regulate DAF-16 and 
knockdown of this candidate results in enhancing DAF-16 activity and increasing dauer formation. DAF-16 
might itself negatively regulate F25D1.1 during low IIS conditions in order to maintain transcriptional 
activity and thus constitute a bistable negative feedback genetic switch. 
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Summary: 
  Phosphorylation is a critical and highly regulated post-translational modification in the cell. Kinases 
and phosphatases are both exquisitely regulated in order to balance the levels of signaling and to mediate 
intended responses. The insulin/IGF-1 signaling cascade is an evolutionarily conserved pathway that 
mediates important cellular and organismal responses such as survival, growth, metabolism, stress and 
lifespan and its dysregulation has implicated in diverse human diseases such as diabetes, cancer and 
dementia.  
The insulin signaling pathway is known to be regulated by tyrosine and serine/threonine 
phosphorylations. The kinases and tyrosine phosphatases regulating the IIS pathway have been extensively 
studied but serine/threonine phosphatases have not been studied in such great detail due to the lack of 
appropriate reagents. In this study we designed an RNAi based screening strategy by utilizing a relatively 
well studied phenotypic output in worms. We utilized dauer formation as a good surrogate for the level of 
activity in the IIS pathway and this allowed us to screen a relatively large number of genes in a sensitive and 
quantitative fashion.  
Our screen has identified several key positive and negative regulators of the C. elegans IIS pathway. 
We recovered known positive regulators of the IIS pathway in worms.  tax-6, for example, has been shown 
to positively regulate IIS. We also identified important negative regulators in this pathway, one of which is 
pptr-1. We have further characterized pptr-1 and show, in the next chapter, that it acts at the level of akt-1 
in IIS and is functionally conserved in regulating mammalian insulin signaling. Further work is needed to 
elucidate the mechanism of regulation of the insulin signaling cascade by these candidates and to verify if 
their homologues have similar conserved function in higher mammals.   
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Dauer modifier screen results 
 
Top 4 candidates suppressing dauer formation by more than 50% of control 
Gene 
Common 
name 
Family 
Number of 
dauers 
Total 
worms 
scored 
(N) 
% 
dauers 
% change relative 
to control RNAi 
Std dev (+/-) 
T19C3.8 fem-2 PP2C 0 388 0 -99 0 
W08G11.4 pptr-1 PP2A-B56 7 411 2 -97 2 
ZK973.3 ZK973.3 PP2C/PDP 32 366 9 -79 5 
ZC477.2 ZC477.2 PP1-like (PP1γ) 70 286 25 -54 6 
 
 
 
Top 16 candidates enhancing dauer formation by more than 50% of control 
Gene 
Common 
name 
Family 
Number of 
dauers 
Total 
worms 
scored 
(N) 
% 
dauers 
% change relative to 
control RNAi 
Std dev (+/-) 
F29F11.6 gsp-1 PP1-like (PP1β) 135 137 99 459 1 
C02F4.2 tax-6 PP2B 132 178 74 320 5 
C23G10.1 C23G10.1 PP1-like 158 210 75 286 9 
F25D1.1 tag-93 PP2C 171 278 62 248 6 
F20D6.6 F20D6.6 PP1-like (PP1α) 132 276 48 170 1 
T16G12.7 T16G12.7 PP1-like 124 207 60 159 19 
W03D8.2 W03D8.2 PP1-like (PP1α) 136 309 44 148 13 
C24H11.1 C24H11.1 PP1-like (PP1β) 95 169 56 143 16 
Y75B8A.30 pph-4.1 PP4 101 107 94 128 14 
R13A5.11 R13A5.11 PP1-like (PP1α) 177 412 43 120 21 
C34D4.2 C34D4.2 PP1-like 165 332 50 115 10 
F49E11.7 F49E11.7 PP1-like (PP1α) 181 379 48 106 9 
C24H11.2 C24H11.2 PP1-like (PP1β) 82 180 46 97 5 
F25B3.4 F25B3.4 PP1-like (PP1β) 94 280 34 89 5 
C34C12.3 pph-6 PP6 132 162 82 84 9 
F56C9.1 gsp-2 PP1-like (PP1α) 153 184 83 75 7 
 
Table 4 
A 
B 
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Phosphatase screen results – individual experiments: 
Table 5 
Gene name 
Number 
of 
dauers 
Total(N) %(dauers) 
% change relative 
to control RNAi 
Std dev 
(+/-) 
Vector 155 326 48 0 1 
Vector(Rpt) 152 322 47 0 3 
daf-18 11 366 3 -44 1 
C30A5.4 115 217 53 6 14 
Y39B6A.2 (pph-5) 122 323 38 -10 13 
F40E3.5 84 331 25 -22 1 
Y54F10BM.1 (fbxa-1) 77 322 24 -23 7 
Y49E10.3 (pph-4.2) 134 269 50 2 3 
F23H11.8 144 350 41 -6 3 
T03F1.5 (gsp-4) 151 337 45 -3 4 
ZK938.1 198 366 54 7 6 
F33A8.6 129 358 36 -11 9 
F56C9.1 (gsp-2) 153 184 83 36 7 
 
Vector 155 285 54 1 5 
Vector(Rpt) 150 281 53 -1 5 
daf-18 1 312 0 -54 1 
T19C3.8 (fem-2) 0 388 0 -54 0 
R08C7.8 114 205 56 2 10 
ZC477.2 70 286 24 -29 6 
C05A2.1 (pph-1) 102 246 41 -12 9 
F26B1.5 92 215 43 -11 15 
F22D6.9 138 315 44 -10 10 
Y54G2A.24 119 250 48 -6 4 
F42G9.1 87 234 37 -17 4 
 
Vector 109 263 41 0 4 
daf-18 3 338 1 -41 1 
ZK973.3 32 366 9 -33 5 
Y75B8A.30 (pph-4.1) 101 107 94 53 14 
C47A4.3 86 346 25 -17 6 
W09C3.6 (gsp-3) 70 295 24 -18 3 
R08A2.2 116 228 51 9 9 
R03D7.8 113 272 42 0 14 
 
Vector 90 203 44 0 4 
daf-18 0 319 0 -44 0 
F52H3.6 116 216 54 9 10 
C06A1.3 155 277 56 12 12 
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F58G1.3 153 238 64 20 7 
C34C12.3 (pph-6) 132 162 81 37 9 
F43C1.1 96 232 41 -3 8 
 
Vector 62 318 20 0 3 
daf-18 0 310 0 -20 0 
R03D7.8 85 281 30 11 10 
C23G10.1 158 210 75 56 9 
R13A5.11 177 412 43 23 21 
 
Vector 90 389 23 0 8 
daf-18 0 362 0 -23 0 
T23F11.1 114 317 36 13 21 
T16G12.7 124 207 60 37 19 
W09D10.4 56 366 15 -8 3 
C24H11.1 95 169 56 33 16 
C24H11.2 82 180 46 22 5 
R08C7.8 30 308 10 -13 8 
ZK354.9 79 380 21 -2 3 
ZC477.2 (pph-5) 29 375 8 -15 5 
C34D4.2 165 332 50 27 10 
F42G8.8 95 356 27 4 1 
C27B7.6 114 403 28 5 9 
T25B9.2 100 389 26 3 4 
Y69E1A.4 144 468 31 8 9 
C42C1.2 81 434 19 -4 1 
F49E11.7 181 379 48 25 9 
 
Vector 71 405 18 0 4 
daf-18 0 395 0 -18 0 
C02F4.2 (tax-6) 132 178 74 56 5 
W03D8.2 136 309 44 26 13 
C47A4.3 22 216 10 -8 2 
C09H5.7 70 280 25 7 9 
F20D6.6 132 276 48 30 1 
C01B7.6 (rpm-1) 59 327 18 0 9 
F25B3.4 94 280 34 16 5 
F25D1.1 (tag-93) 171 278 62 43 6 
F29F11.6 (gsp-1) 135 137 99 81 1 
C05A2.1 (fbxa-1) 60 396 15 -3 8 
F23B12.1 104 391 27 9 2 
Y40H4A.2 46 237 19 1 6 
C44H4.5 (tap-1) 51 315 16 -2 6 
 
(Table 5 Continued)  
  54 
 
 
Acknowledgements for Chapter III: 
A major portion of this section of the dissertation is taken from our paper: 
Padmanabhan, S.*, Mukhopadhyay, A.*, Narasimhan, SD*., Tesz, G., Czech, M. P., and Tissenbaum, H. A. 
(2009).  A PP2A regulatory subunit, PPTR-1, regulates C. elegans insulin signaling by modulating AKT-1 
phosphorylation. Cell 136, 939-51 
(*co-first author) 
See Statement of Contribution for individual experiments 
 
 
  
  
  55 
 
CHAPTER III 
Characterization of PPTR-1 
Abstract: 
 The C. elegans insulin/IGF-1 signaling (IIS) cascade plays a central role in the regulation of lifespan, 
dauer diapause, metabolism and stress response. The major regulatory control of IIS is through 
phosphorylation of its components by serine/threonine-specific protein kinases. In an RNAi screen for 
serine/threonine protein phosphatases that counteract the effect of the kinases in the IIS pathway, we 
identified pptr-1, a B56 regulatory subunit of the PP2A holoenzyme.  Modulation of pptr-1 affects 
phenotypes associated with the IIS pathway including life span, dauer, stress resistance and fat storage. We 
show that PPTR-1 functions by regulating worm AKT-1 phosphorylation at Thr 350. With striking 
conservation, mammalian B56β regulates Akt phosphorylation at Thr 308 in 3T3-L1 adipocytes.  In C. 
elegans, this modulation ultimately leads to changes in subcellular localization and transcriptional activity 
of the forkhead transcription factor DAF-16. This work reveals a conserved role for the B56 regulatory 
subunit in modulating insulin signaling through AKT dephosphorylation and thereby has widespread 
implications in cancer and diabetes research. 
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Results 
The second top candidate that suppressed dauer formation of daf-2(e1370) was pptr-1(Figure 13A). 
pptr-1 (W08G11.4), is a member of the B56 family of genes encoding regulatory subunits of the PP2A 
protein phosphatase holoenzyme. The C. elegans genome contains 7 known PP2A regulatory subunit genes 
(pptr-1 and pptr-2, B56 family; sur-6, B55 family; F47B8.3, C06G1.5, rsa-1 and T22D1.5, B72 family; 
currently F47B8.3 is not annotated as a PP2A regulatory subunit according to WormBase Release WS200). 
To determine the specificity of pptr-1 in regulating dauer formation, we re-tested the six PP2A regulatory 
subunits included in the screen for their ability to regulate dauer formation in daf-2(e1370). As shown in 
Figure 13B, only pptr-1 RNAi suppressed daf-2(e1370) dauer formation comparable to daf-18 RNAi.   
We next analyzed the effect of pptr-1 RNAi on dauer formation of daf-2(e1368). pptr-1 RNAi 
significantly suppressed the dauer formation of daf-2(e1368) (84.6 ± 25.3 % on vector RNAi versus  19.8 ± 
10.7 % on pptr-1 RNAi; (Table 6). Therefore the effect of pptr-1 RNAi on daf-2 mutants is not allele-specific. 
Together these results indicate that pptr-1 may function downstream of daf-2.   
pptr-1 regulates dauer formation through the IIS pathway 
To further investigate the role of pptr-1 in dauer formation, we performed genetic epistasis 
analysis.  In addition to the  C. elegans IIS pathway, a second parallel TGF-β pathway also regulates dauer 
formation (Patterson and Padgett 2000; Savage-Dunn 2005).  In this pathway, loss of function mutations in 
daf-7 (TGF- β ligand), daf-1 and daf-4 (receptors) or daf-14 and daf-8 (R-Smads) lead to constitutive dauer 
formation; loss-of-function mutations in daf-3 (Co-Smad) or daf-5 (Sno/Ski) suppress these phenotypes 
(Ren, Lim et al. 1996; Patterson, Koweek et al. 1997; Gunther, Georgi et al. 2000; Inoue and Thomas 2000; 
da Graca, Zimmerman et al. 2004).  However, null mutations in daf-3 do not suppress daf-2(e1370) dauer  
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Figure 13 
RNAi % Dauer ± Std. Dev. (n)
vector 17.5 ± 3.7 405
daf-18 0.0 ± 0.0 395
pptr-1 1.3 ± 1.6 470
A
B
pptr-1, a regulatory subunit of the PP2A holoenzyme, was identified 
as a top candidate in a directed RNAi screen to identify 
serine/threonine phosphatases that regulate the IIS pathway.
pptr-1 is the only PP2A regulatory subunit family member that 
dramatically suppresses daf-2(1370) dauer formation. Error bars 
indicate the standard deviations among the different RNAi plates 
within one experiment. 
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formation (Vowels and Thomas 1992). Similarly, the current understanding is that, mutations in daf-16 do 
not suppress daf-7 dauer formation. In order to investigate if the role of pptr-1 in dauer formation was 
exclusively through the insulin-signaling pathway we attempted to make a daf-7(e1372);daf-16(mgdf50) 
double. However, all recovered dauers were found to be wild-type for daf-16(data not shown). This 
indicated that daf-16 activity is required for daf-7 dauer formation. To investigate the requirement of 
insulin signaling components in TGF-β pathway we knocked down daf-16, daf-18 and pptr-1 by RNAi in daf-
7 (e1372) worms (Table 6). All three RNAi vectors significantly suppressed daf-7 dauer formation, with daf-
16 RNAi being most efficient (0% dauers at 25oC). All previously published epistasis analysis were done with 
daf-16 point mutant (hypomorphic) alleles which were able to suppress daf-2 dauer formation but probably 
had sufficient basal activity to allow the TGF-β pathway mutants to form dauers.  In order to identify if the 
dauer suppression phenotype of pptr-1 RNAi was because of its action in insulin/IGF-1 or the TGF-β 
pathway we decided to use an alternative approach. 
 In a daf-2(e1370);daf-3(mgDf90) double mutant, the input from the TGF- β pathway for dauer 
formation is essentially removed.  In this strain, the dauer formation of daf-2(e1370);daf-3(mgDf90) worms 
was suppressed by pptr-1 RNAi (87.6 ± 18.1 %  dauers on vector RNAi to 28.4 ± 12.1. % dauers on pptr-1 
RNAi (Table 7); This data suggests that pptr-1 controls dauer formation specifically through the IIS pathway 
and not the TGF-β pathway. 
pptr-1 affects longevity, metabolism and stress response downstream of the IIS receptor 
 In addition to dauer formation, the C. elegans IIS pathway also regulates life span, fat storage and 
stress resistance (Barbieri, Bonafe et al. 2003; Mukhopadhyay, Oh et al. 2006). Since pptr-1 regulates dauer 
formation specifically via the IIS pathway, we next determined whether this gene could also affect these 
other important phenotypes.  
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RNAi %dauer± stddev 
 
(n) 
Vector 42±26 
 
596 
daf-18 21±2 
 
345 
pptr-1 7±3 
 
490 
 
 
Dauer formation in daf-7(e1372) worms upon RNAi. daf-7(e1372) on daf-16 RNAi showed 0%     
dauers  in an independent experiment.  
 
 
 
 
 
 
 
 
Table 6 
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Mutations in daf-2 result in life span extension (Kenyon, Chang et al. 1993) that is suppressed by 
loss-of-function mutations in daf-18 (Dorman, Albinder et al. 1995; Mihaylova, Borland et al. 1999).  To 
investigate whether pptr-1 can regulate life span similar to daf-18, we determined whether knocking down 
pptr-1 by RNAi could affect daf-2(e1370) life span.  We grew wild type and daf-2(e1370) worms on vector, 
daf-18 and pptr-1 RNAi and measured their life span (Figure 14).  Similar to daf-18 RNAi, knock down of 
pptr-1 resulted in a significant reduction in daf-2(e1370) life span (mean life span of daf-2(e1370) on vector 
RNAi is 33.9 ±  0.7 days , on pptr-1 RNAi is  27.7 ± 0.9 days and on daf-18 RNAi is 20.4 ± 0.6 days , p value < 
0.0001; Figure 14).  In contrast, lifespan of wild type worms was unaffected by pptr-1 RNAi (mean lifespan 
of wild type on vector RNAi is 22.8 ± 0.4 days, is  21.9 ±  0.5 days on pptr-1 RNAi and 18.6 ± 0.3 days on daf-
18 RNAi ; Figure 15). Thus, pptr-1 affects phenotypes regulated by the IIS pathway, such as life span as well 
as dauer formation.  
Life span extension correlates well with increased stress resistance (Lithgow and Walker 2002; Oh, 
Mukhopadhyay et al. 2005). For example, daf-2(e1370) mutants are not only long-lived but are also 
extremely resistant to various stresses such as heat and oxidative stress (Lithgow, White et al. 1995; Honda 
and Honda 1999; Munoz 2003). Therefore, we next analyzed the effect of pptr-1 RNAi on the 
thermotolerance of daf-2(e1370) mutants. As anticipated, pptr-1 RNAi also significantly reduced the 
thermotolerance of daf-2(e1370) mutants (on vector RNAi, daf-2(e1370) had a mean survival of 15.2 ± 0.7 
hrs, whereas on pptr-1 RNAi the survival was 13.8 ± 0.5 hrs (p value< 0.006). pptr-1 RNAi did not affect the 
thermotolerance of wild type worms; mean thermotolerance was 9.8 ± 0.4 hrs on vector RNAi, versus 9.3 ± 
0.3 hrs on pptr-1 RNAi;Figure 16). 
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daf-2 (daf-18)
Time (days)
pptr-1 RNAi significantly reduces the life span of daf-2(e1370) mutants similar 
to daf-18 RNAi (mean life on vector RNAi is 33.9 ± 0.7 days (n=77), pptr-1 RNAi
is 27.7 ± 0.9 days (n=63) p <0.0001and on daf-18 RNAi is 20.4 ± 0.6 days 
(n=40), p <0.0001)
 
Figure 14 
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pptr-1 RNAi does not affect the life span of wild-type worms (mean life span 
on vector RNAi is 22.8 ± 0.4 days (n=61), pptr-1 RNAi is 21.9 ± 0.5 days 
(n=49). daf-18 RNAi reduces mean life span of wild type worms to 18.6 ± 0.3 
days (n=48) p <0.0001). 
 
Figure 15 
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Thermotolerance of daf-2(e1370) worms is reduced by pptr-1 as well as daf-18 
RNAi (mean survival of daf-2(e1370) worms at 37oC on vector RNAi was 15.2 ±
0.7 hrs (n=34), whereas on pptr-1 RNAi the survival was 13.8 ± 0.5 hrs (p 
value< 0.006) (n=36) and 10.3 ± 0.7 hrs (p value< 0.0001) (n=29) on daf-18
RNAi.  pptr-1 RNAi did not affect the thermotolerance of wild type worms; (mean 
survival was 9.8 ± 0.4 hrs on vector RNAi (n=32), 9.3 ± 0.3 hrs on pptr-1 RNAi
(n=35) and 9.7 ± 0.4 hrs on daf-18 RNAi (n=32).
 
Figure 16 
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Control pptr-1 daf-18 vector pptr-1 daf-18
Wild type
daf-2
Fat storage
Sudan black fat staining: pptr-1 RNAi reduces the increased fat storage of 
daf- 2(e1370) worms, similar to daf-18 RNAi but has no effect on wild 
type fat-storage. Arrows indicate the pharynx.
 
Figure 17 
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In addition to enhanced life span and stress resistance, daf-2 mutants have increased fat storage 
(Kimura, Tissenbaum et al. 1997; Ashrafi, Chang et al. 2003). We next asked whether pptr-1 could also 
affect fat storage in wild type and daf-2(e1370) worms using Sudan black staining.  Consistent with our life 
span and stress resistance results,  pptr-1 RNAi suppressed the increased fat storage of daf-2(e1370) 
without affecting wild type fat storage (Figure 17). Together, these experiments suggest that pptr-1 
regulates multiple phenotypes associated with the IIS pathway in C. elegans. 
pptr-1 functions at the level of akt-1 
Signals from DAF-2 are transduced to the PI 3-kinase AGE-1 to activate the downstream 
serine/threonine kinase PDK-1 (Dorman, Albinder et al. 1995; Morris, Tissenbaum et al. 1996; Paradis, 
Ailion et al. 1999). PDK-1 in turn phosphorylates and activates three downstream serine/threonine kinases, 
AKT-1, AKT-2 and SGK-1 (Paradis and Ruvkun 1998; Hertweck, Gobel et al. 2004). These kinases together 
regulate the transcription factor DAF-16 by direct phosphorylation (Baumeister and Hertweck 2004).  
Mutations in daf-16 suppress the enhanced dauer formation of pdk-1 (Paradis, Ailion et al. 1999) or akt-
1/akt-2 mutants (Paradis and Ruvkun 1998; Oh, Mukhopadhyay et al. 2005).  Thus far, our analysis suggests 
that pptr-1 functions in the IIS pathway.  We therefore sought to identify the potential target of pptr-1 by 
performing genetic epistasis experiments.  
First we analyzed the effect of pptr-1 RNAi on dauer formation of the pdk-1(sa680) a putative null 
mutant. The dauer formation of pdk-1(sa680) was suppressed by pptr-1 RNAi (95.6±1% dauers on vector 
RNAi versus 9.5 ± 0.3 % dauers on pptr-1 RNAi at 25oC (Table 7). pdk-1 (sa680) worms were sick on daf-18 
RNAi and had no effect on pdk-1(sa680) dauer formation or growth.  Therefore, these results place pptr-1 
downstream of pdk-1 and are consistent with the current understanding that daf-18 acts upstream of pdk-
1. Next, to investigate whether pptr-1 acts at the level of akt-1, akt-2 or sgk-1, we first analyzed dauer  
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         Epistasis analysis of dauer formation using different IIS pathway mutants on RNAi. 
 
All strains were maintained at 15°C and assays were performed at 20°C, unless indicated otherwise. Also, dauer 
formation of all strains was scored after 3.5-4 days, unless indicated otherwise. Data shown is representative of one 
experiment.  
a
 The experiment was performed at 25 
o
C  
b
 Dauers were scored after 5 days.  
c
 In most experiments, the pdk-1(sa680) worms failed to hatch on daf-18 RNAi. This number represents 20% of the 
eggs picked for this assay. 
d 
Dauers were scored after 7-8 days. For daf-2(e1370);akt-1(ok525) worms on vector or pptr-1 RNAi, all the non-
dauers were either partial dauers   or dauer-like. They did not develop into adults even after 2 weeks.  
e
 Dauers were scored after 7-8 days. The daf-2(e1370);sgk-1(ok538) strain shows a gro phenotype and worms remain 
at the L1/L2 stage for 6-7 days at 20°C.  
f
 The daf-2(e1370);akt-1(ok525) at 19.2 
o
C 
 
Table 7 
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formation in  akt-1(ok525), akt-2(ok393) and sgk-1(ok538) single mutants and the akt-1(ok525);akt-
2(ok393) double mutant. While akt-1(ok525), akt-2(ok393) and sgk-1(ok538) single mutants  do not arrest 
as dauers at either 20 or 25 oC, the akt-1(ok525);akt-2(ok393) double mutant forms 100% dauers at all 
temperatures (Oh, Mukhopadhyay et al. 2005). To circumvent this problem, we generated double mutants 
of daf-2(e1370);akt-1(ok525), daf-2(e1370);akt-2(ok393) and daf-2(e1370);sgk-1(ok538) and tested these 
strains for dauer formation on vector, daf-18 and pptr-1 RNAi.  We reasoned that in a daf-2 mutant 
background, the akt-1, akt-2 and sgk-1 mutants would exhibit temperature-induced dauer formation. 
Indeed, all three double mutants were able to form dauers at 20oC. Importantly, pptr-1 RNAi significantly 
suppressed dauer formation in daf-2(e1370);akt-2(ok393) (45.6± 6.7% dauers on vector RNAi versus 1.1± 
0.8  % on pptr-1 RNAi); In addition, pptr-1 RNAi suppressed dauer formation of daf-2(e1370);sgk-1(ok538) 
worms (58.9± 3.6 % dauers on vector RNAi versus 1.5± 0.9 on pptr-1 RNAi). In contrast, pptr-1 RNAi did not 
affect dauer formation of daf-2(e1370);akt-1(ok525) mutants (vector RNAi is 85.3± 5.8 % versus 89.9± 1.6 % 
on pptr-1 RNAi).  However, daf-18 RNAi  can suppress daf-2(e1370) akt-1(ok525) dauer formation ( reduced 
to 10.5 ± 0.8%;) Table 7.  
Although the dauer formation was not significantly different there was an important caveat to this 
experiment. The daf-2(e1370) akt-1(ok525) behaves differently from daf-2(e1370) alone by being enhanced 
for dauer formation at 20oC. The non-dauer category in this experiment was fat and dark dauer-like animals 
with occasional pharyngeal pumping. These animals never exited this stage even after prolonged periods at 
20oC (plates were followed for more than 1 month). This raised a caveat that the RNAi phenotype of pptr-1 
was too weak to suppress dauer formation in this strain. Therefore we decided to perform the experiment 
at a lower temperature that allowed development to proceed but still allowed some worms to enter the 
dauer stage. We identified 19.2oC as the best temperature for this experiment.  We did not find any 
difference in dauer formation at this temperature between vector (82.1± 1 %) and pptr-1 (84± 0.8 %) 
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indicating that in the absence of akt-1, pptr-1 is unable to affect dauer formation in daf-2(e1370) mutants. 
These observations genetically place pptr-1 at the level of akt-1 in the IIS pathway.  
PPTR-1 and AKT-1 are expressed in the same tissues 
Since pptr-1 and akt-1 genetically interact, we wanted to investigate whether they have a common 
expression pattern. We generated or obtained akt-1::gfp, akt-2::gfp, sgk-1::gfp and pptr-1::mC-flag 
transgenic lines (see Materials and Methods; GFP refers to protein while gfp stands for transgene).  We 
made double transgenic worms by crossing pptr-1::mC-flag worms to each of the above-mentioned GFP 
lines. Similar to published data, we observed AKT-1::GFP predominantly in the pharynx, several head 
neurons, the nerve ring, spermathecae and vulva (Paradis and Ruvkun 1998)(Figure 18); AKT-2::GFP in the 
pharynx (predominantly in the anterior region), somatic muscles, vulva muscles, spermathecae(Figure 19) 
(Paradis and Ruvkun 1998); SGK-1::GFP in amphid neurons, intestine and some tail neurons (Hertweck, 
Gobel et al. 2004) (Figure 20).  PPTR-1::mC-FLAG was also observed in the pharynx, head neurons, nerve 
ring, spermathecae and vulva (Figure 18). To observe the sub-cellular localization of PPTR-1, we stained 
pptr-1::mC-flag worms with DAPI. We find that PPTR-1 is predominantly cytosolic with little DAPI overlap 
(Figure 21).  
As shown in Figure 18(Merge), there is remarkable overlap between the expression patterns of PPTR-1 and 
AKT-1.  We also observed partial overlap between AKT-2::GFP and PPTR-1::mC-FLAG, predominantly in the 
pharynx (Figure 19). SGK-1 and PPTR-1 are expressed in different tissues and we do not see any significant 
overlap (Figure 20). 
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PPTR-1 co-localizes with AKT-1. akt-1::gfp;pptr-1::mC-flag, transgenic worms 
were mounted and visualized by fluorescence microscopy using Rhodamine
(mCherry) and FITC (GFP) filters. PPTR-1 expression is observed mainly in the 
pharynx, vulva and spermatheca.
Expression of PPTR-1::mC-FLAG (mCherry) and AKT-1::GFP (GFP) in a akt-1::gfp; 
pptr-1::mC-flag strain. 
Expression of PPTR-1::mC-FLAG completely overlaps with AKT-1::GFP (merge).
Overlap is seen in pharynx, spermatheca, vulva, head neurons, tail neurons and 
coelomocytes.
 
Figure 18 
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PPTR-1 partially co-localizes with AKT-2. akt-2::gfp;pptr-1::mC-flag, transgenic 
worms were mounted and visualized by fluorescence microscopy using 
Rhodamine (mCherry) and FITC (GFP) filters. PPTR-1 expression is observed 
mainly in the pharynx, vulva and spermatheca (A-C, mCherry).
Expression of PPTR-1::mC-FLAG (mCherry) and AKT-2::GFP (GFP) in a akt-
2::gfp; pptr-1::mC-flag strain. 
PPTR-1::mC-FLAG and AKT-2::GFP colocalize partially (in anterior pharynx, 
spermatheca and vulva). akt-2::gfp (but not PPTR-1::mC-FLAG ) is present in somatic 
muscle and germline whereas pptr-1::mCherry (but not AKT-2::GFP) is present in 
head neurons and anterior pharynx.
 
Figure 19 
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PPTR-1 does not co-localize with SGK-1. sgk-1::gfp;pptr-1::mC-flag, transgenic 
worms were mounted and visualized by fluorescence microscopy using 
Rhodamine (mCherry) and FITC (GFP) filters. PPTR-1 expression is observed 
mainly in the pharynx, vulva and spermatheca.
Expression of PPTR-1::mC-FLAG and SGK-1::GFP (merge) is completely different.
 
Figure 20 
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Upper panel: High resolution image of in pptr-1::mC-flag stained with DAPI at 600 X 
magnification. Arrow indicates the pharynx. (A) mCherry (B) DAPI (C) Merge  (D) DIC. 
Lower panel: Subcellular localization of PPTR-1 as visualized in a single plane by 
spinning disk confocal microscopy after DAPI staining to delineate nuclei. Left, middle 
and right panels are mCherry at 561nm, DAPI at 405nm and the merge respectively 
 
Figure 21 
  73 
 
 PPTR-1 regulates AKT-1 phosphorylation 
Given the genetic epistasis as well as the overlapping expression patterns, we next determined 
whether PPTR-1 directly interacts with AKT-1 by co-immunoprecipitation (co-IP) in C. elegans. For all 
biochemical experiments, we used the PD4251 strain as a control. This strain contains Pmyo-3::gfp with a 
mitochondrial localization signal and Pmyo-3::lacZ-gfp with a nuclear localization signal (Fire, Xu et al. 
1998). This strain will be referred to as myo-3::gfp. We prepared lysates from mixed-stage akt-1::gfp; pptr-
1::mC-flag and myo-3::gfp; pptr-1::mcherry-flag transgenic worms.  Following immunoprecipitation with 
either anti-FLAG or anti-GFP antibody, we found that PPTR-1 specifically interacts with AKT-1 and not with 
MYO-3::GFP (Figure 22). We also performed co-IP experiments to investigate whether PPTR-1 and AKT-2 
interact, since we observed partial overlap in expression pattern of these proteins. We find that PPTR-1 
does not interact with AKT-2. Although we find that PPTR-1::mC-FLAG and SGK-1::GFP interact in our co-IP 
experiments(Figure 23), our epistasis analyses show no genetic interaction between pptr-1 and sgk-1. 
Moreover, we observe no overlap in the expression pattern of these two proteins using confocal 
microscopy. Hence, we do not believe this biochemical interaction to have a measurable functional output 
and did not pursue it further.   
In mammals, Akt is activated by PDK phosphorylation at Thr 308 and PDK-2/TORC-2 protein 
complex at Ser 473 (Brazil and Hemmings 2001; Sarbassov, Guertin et al. 2005; Jacinto, Facchinetti et al. 
2006). In C. elegans AKT-1, these sites correspond to Thr 350 and Ser 517, respectively. We generated 
affinity-purified phospho-specific antibodies (21st Century BioChemicals, USA; see Materials and Methods) 
against both sites to further investigate the role of PPTR-1 on AKT-1 phosphorylation.  
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PPTR-1 directly interacts with AKT-1 in C. elegans. 
AKT-1::GFP and MYO-3::GFP were immunoprecipated (IP) from akt-1::gfp;pptr-1::mC-
flag(1,5) and myo-3::gfp;pptr-1::mC-flag(2,6) strains using anti-GFP antibody and were 
analyzed by western blotting (WB) using anti-Ds-Red or anti-GFP antibodies. (3 – N2
lysate, 4-AKT-1::GFP alone control lysates)
IP Lysate
 
Figure 22 
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Lysate
WB: GFP
WB: Ds-Red
IP
IP: Flag
PPTR-1 directly interacts with AKT-1 in C. elegans but not with DAF-16, AKT-2 or GFP (control). We 
observe a biochemical interaction between PPTR-1 and SGK-1 in our co-IP experiments but do not see a 
genetic interaction or any tissue overlap between these proteins,  PPTR-1::mC-FLAG was 
immunoprecipated (IP) from  akt-1::gfp;pptr-1::mC-flag,  akt-2::gfp;pptr-1::mC-flag, sgk-1::gfp;pptr-
1::mC-flag , daf-16::gfp;pptr-1::mC-flag and myo-3::gfp;pptr-1::mC-flag using anti-FLAG antibody and 
interactions with AKT-1::GFP, AKT-2::GFP,  SGK-1::GFP, DAF-16::GFP or MYO-3::GFP (control) and were 
analyzed by western blotting (WB) using anti-GFP or anti-Ds-Red antibodies. 
Figure 23 
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Following immunoprecipitation with anti-GFP antibody from either akt-1::gfp or akt-1::gfp;pptr-
1::mC-flag strain, we compared the phosphorylation status at these two sites. We find that overexpressing 
PPTR-1 can dramatically decrease the phosphorylation of the T350 site while having a marginal effect on 
the Ser 517 site (Figure 24). As a control experiment, we treated the immunoprecipitated AKT-1::GFP 
samples with lambda phosphatase and observed loss of the Thr and Ser phosphorylation, showing the 
specificity of the phospho-AKT antibodies (Figure 25).  Thus, in C. elegans, PPTR-1 functions by directly 
regulating the dephosphorylation of AKT-1 primarily at the Thr 350 (mammalian Thr 308) site. 
Mammalian PPTR-1 homolog regulates AKT-1 phosphorylation 
Given the evolutionary conservation of the C. elegans IIS pathway, we next determined if this 
mechanism of AKT-1 dephosphorylation mediated by PPTR-1 is also conserved in mammals. The 
mammalian B56 family of PP2A regulatory subunits has 8 members encoded by 5 genes that express in 
different tissues (Eichhorn, Creyghton et al. 2008). We used 3T3-L1 adipocytes to perform these studies 
since in this system, there is a well-characterized insulin signaling pathway that is responsive to changes in 
insulin levels (Ugi, Imamura et al. 2004; Watson, Kanzaki et al. 2004).  We used microarray data comparing 
the expression profiles of fibroblasts to differentiated 3T3-L1 adipocytes (Powelka, Seth et al. 2006) to 
determine which B56 members were expressed in the adipocytes.  We identified 2 genes, PPP2R5A (B56α) 
and PPP2R5B (B56β) as the top candidates. We knocked down either one or both these regulatory subunits 
by designing Smartpool siRNAs (Dharmacon, USA) and verified the silencing by quantitative RT PCR (Figure 
27). Serum-starved siRNA-treated 3T3-L1 adipocytes were then stimulated with increasing concentrations 
of insulin. The cells were lysed and the proteins analyzed by western blotting using mammalian Akt 
phospho-specific antibodies (see Materials and Methods).   
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AKT-1 pThr 350 AKT-1 pSer 517
GFP Ab GFP Ab
IP
Lysates
1           0.28                            1            0.56  
PPTR-1 overexpression reduces AKT-1 phosphorylation in C. elegans. 
AKT-1::GFP and MYO-3::GFP were immunoprecipitated from  akt-1::gfp, 
akt-1::gfp;pptr-1::mC-flag and myo-3::gfp;pptr-1::mC-flag followed by 
western blotting using pThr 350 or pSer 517 antibodies (upper panels). 
Total lysates were analyzed by western blotting (lower panels).
Quantification of changes in AKT-1::GFP phosphorylation upon PPTR-1 
overexpression is shown below each lane.
 
Figure 24 
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Determination of the specificity of the C. elegans phospho-AKT 
antibodies. L2/L3 (Lanes 1, 3 and 5) or mixed stage (Lanes 2, 4 and 6) 
akt-1::gfp worms were lysed and AKT-1::GFP was immunoprecipitated
using anti-GFP antibody (Lanes 3-6). The immunoprecipitated
proteins were resolved by SDS-PAGE and blotted to PVDF membrane. 
Lanes 5 and 6 of the membrane were cut out and treated with Lambda 
phosphatase. The treated as well as the untreated blots were probed 
with anti-phospho Thr 350 or Ser 517 antibodies. 
 
Figure 25 
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Knock down of the mammalian B56β regulatory subunit by siRNA in 3T3-L1 
adipocytes increases insulin-stimulated AKT phosphorylation at Thr 308. 
3T3-L1 adipocytes were transfected with scrambled (Scr), PP2Acα/β, B56α, B56 β
or B56α/β siRNA. These cells were then treated with increasing concentrations of 
insulin and phosphorylation status of Akt was analyzed by western blotting using 
pThr 308 (left) and pSer 473 antibodies (middle). Total Akt antibody was used as a 
loading control (right). Quantification of fold changes in Akt phosphorylation is 
shown below each lane.
WB: pThr 308 pSer 473 Total Akt
0 0.1 1 100
Insulin (nM)
Scr
PP2Ac α/β
B56α
B56β
B56α/β
0 0.1 1 100 0 0.1 1 100
siRNA
1 0.5 0.7 1 1 0.8 2.2 3.3
1 0.7 2.1 2 1 1.3 4.1 4.3
1 0.7 1.4 1.4 1 0.8 2.9 5.8
1 1 1.8 4.5 1 1 2.7 5
1 1.1 1.6 2.8 1 0.9 2.4 5.5
 
Figure 26 
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Knockdown of B56β results in a dramatic increase in phosphorylation at the Thr 308 site of Akt with 
relatively modest changes in Ser 473 phosphorylation(Figure 26). However, silencing of B56α had no effect 
on the phosphorylation status of Akt at either site. We observed that siRNA against both the PP2A catalytic 
subunits (PP2Acα/β) results in increased phosphorylation at Thr 308 but not at Ser 473.  Together, these 
data suggest that PPTR-1/B56β subunit mediated regulation of IIS/AKT-1 is evolutionarily conserved. 
 
PPTR-1 positively regulates DAF-16 nuclear localization and activity 
DAF-16 nuclear localization 
We next determined the consequences of modulating PPTR-1 dosage on the IIS pathway.  In C. 
elegans, one of the major targets of AKT-1 is the forkhead transcription factor, DAF-16. Active signaling 
through the IIS pathway results in the phosphorylation of DAF-16 by AKT-1, AKT-2 and SGK-1, leading to its 
nuclear exclusion. However, under low signaling conditions, DAF-16 translocates into the nucleus, where it 
can directly bind and activate/repress the transcription of target genes involved in dauer formation, life 
span, stress resistance and fat storage (Oh, Mukhopadhyay et al. 2006).  We asked whether pptr-1 
regulates IIS pathway-specific phenotypes by modulating DAF-16 function.  Since we observed reduced 
phosphorylation of AKT-1 upon overexpression of PPTR-1, we first looked at the effect of PPTR-1 
overexpression on DAF-16 nuclear localization (Henderson and Johnson 2001; Lee, Hench et al. 2001; Lin, 
Hsin et al. 2001). We generated a daf-16::gfp;pptr-1::mC-flag strain and compared the DAF-16 nuclear 
localization in these worms with a daf-16::gfp strain (daf-16::gfp, a kind gift from the Ruvkun lab). We 
categorized DAF-16::GFP localization as completely cytosolic, mostly cytosolic, mostly nuclear or 
completely nuclear. We find that DAF-16::GFP nuclear localization is enhanced when PPTR-1 is 
overexpressed (Table 8A).  
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A) Over-expression of PPTR-1 promotes DAF-16 nuclear translocation. 
On vector RNAi, DAF-16 is more enriched in the nucleus in a pptr-
1::mC-flag;daf-16::gfp strain, compared to a daf-16::gfp strain.  This 
effect is specific to the functional transgene, as knocking down pptr-
1::mC-flag with mCherry RNAi decreases the extent of nuclear DAF-16.
B) In a daf-2(e1370);daf-16::gfp strain, DAF-16 is enriched in the 
nucleus on vector RNAi, whereas on pptr-1 RNAi as well as daf-18 
RNAi, DAF-16 is mostly cytosolic. 
 
Table 8 
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Determination of specificity of siRNA knockdown.
The 3T3-L1 adipocytes were transfected with scrambled (Scr), 
PP2Aca/b, B56a, B56 b or B56a/b siRNA (indicated at the bottom of 
each graph). Total RNA was isolated from the adipocytes and 
quantitative RT-PCR analysis was performed to determine the 
efficiency of knock down of each gene (indicated at the top of each 
graph).
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Figure 27 
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A)pptr-1 RNAi affects DAF-16 transcriptional activity. sod-3 is one of 
the direct targets of DAF-16. pptr-1 RNAi reduces Psod-3::GFP 
expression in a daf-2(e1370);Psod-3::gfp(muIs84) strain, similar to 
daf-18 RNAi. 
B)Transcript abundance of known DAF-16 target genes decrease 
when daf-2(e1370) worms are grown on pptr-1 RNAi, similar to daf-
18 RNAi, as detected by real-time PCR
 
Table 9 
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To determine the specificity of this response, we used mCherry RNAi to effectively knock down mCherry 
expression in pptr-1::mC-flag thereby reducing the expression levels of pptr-1 transgene . Our results show 
that the enhanced nuclear localization upon PPTR-1 overexpression is suppressed when pptr-1::mC-
flag;daf-16::gfp worms are grown on mCherry RNAi (Table 8A). However, mCherry RNAi has little effect on 
DAF-16 localization in daf-16::gfp worms. These experiments suggest that increased dosage of pptr-1 
affects DAF-16 nuclear localization. Consistent with its role in the C. elegans IIS pathway, we find that 
overexpression of pptr-1 significantly increases the life span of wild type worms (Figure 28); mean life span 
of wild type  is 23.9 ± 0.3 days, pptr-1::mC-flag is 30.1 ± 0.5 days, p<.0001, and the unc-119(+); unc-
119(ed3)  control strain is 22.6 ± 0.3 days).  
As a corollary to this experiment, we next looked at the effect of pptr-1 RNAi on DAF-16 nuclear 
localization. For this, we generated a strain with a daf-2(e1370);daf-16::gfp strain. At the permissive 
temperature of 15oC, DAF-16::GFP is excluded from the nucleus in the daf-2(e1370);daf-16::gfp strain. 
However, at the non-permissive temperature of 25 oC, progressive nuclear localization of DAF-16::GFP is 
observed. We grew daf-2(e1370);daf-16::gfp worms on either vector, pptr-1 or daf-18 RNAi and measured 
the extent of nuclear localization at 25 oC. We find that pptr-1 RNAi significantly reduced DAF-16 nuclear 
localization, similar to the effect of daf-18 RNAi (Table 8B). Together, these experiments suggest that 
changes in PPTR-1 levels affect the activity of AKT-1 and as a result, modulate DAF-16 sub-cellular 
localization 
DAF-16 target genes 
DAF-16 regulates the transcription of many downstream genes such as sod-3, hsp-12.6, sip-1 and 
mtl-1 (Furuyama, Nakazawa et al. 2000; Lee, Kennedy et al. 2003; McElwee, Bubb et al. 2003; Murphy, 
McCarroll et al. 2003; Oh, Mukhopadhyay et al. 2006).  We next tested the effects of pptr-1 RNAi on these 
DAF-16 transcriptional targets.  We first tested sod-3 which has been shown to be a direct target of DAF-16 
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by chromatin immunoprecipitation (Oh, Mukhopadhyay et al. 2006) and its expression changes in response 
to modulation of the IIS pathway (Furuyama, Nakazawa et al. 2000; Libina, Berman et al. 2003). We grew a 
daf-2(e1370);Psod-3::gfp(muIs84) strain on either vector, daf-18 or pptr-1 RNAi to look at the  effect on 
GFP expression.  Similar to worms grown on daf-18 RNAi, pptr-1 RNAi reduces expression of GFP (Table 9A).  
Therefore, modulation in the levels of pptr-1 can affect the expression of direct DAF-16 target genes.   
We further analyzed the expression of known DAF-16 target genes by quantitative RT-PCR in a daf-
2(e1370) mutant background.  As a control, we analyzed whether each of these target genes expressed in a 
daf-16-dependent manner as previously reported (McElwee, Bubb et al. 2003; Murphy, McCarroll et al. 
2003; Oh, Mukhopadhyay et al. 2006). As shown in Table 9B, daf-16 RNAi dramatically suppressed the 
expression levels of these genes.  Next, we tested the effects of either pptr-1 or daf-18 RNAi on the 
expression of these genes.  We found that pptr-1 RNAi also suppressed the expression of these genes to a 
level similar to daf-18 RNAi.  Taken together, our data suggests that PPTR-1 positively regulates DAF-16 
nuclear localization and thereby its activity. 
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Overexpression of PPTR-1 significantly increases the life span of 
wild type worms. Mean life span of wild type worms is 23.9 ± 0.3 
days (n=154), pptr-1::mC-flag is 30.1 ± 0.5 days (n=202), p<.0001, 
and the unc-119(+); unc-119(ed3) control strain is 22.6 ± 0.3 days 
(n=145).
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Model illustrating the role of PPTR-1 in the insulin/IGF-1 signaling 
pathway. Signals from DAF-2 transduced by a PI3-kinase pathway then 
leads to the phosphorylation and activation of downstream 
serine/threonine kinases such as PDK-1, AKT-1, AKT-2 and SGK-1. 
PPTR-1, the PP2A  holoenzyme regulatory subunit,  regulates the 
dephosphorylation and activation status of AKT-1 at T350 when 
upstream signaling is reduced. This in turn affects the nuclear 
translocation, activity of DAF-16 and results in the expression of genes 
involved in life span, dauer formation, stress resistance and fat storage
 
Figure 29 
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Discussion 
 The insulin/IGF-1 (IIS) signaling pathway regulates growth, metabolism and longevity across 
phylogeny. Given the large number of cellular processes that this pathway controls, understanding the 
mechanisms that modulate IIS is of paramount importance. IIS is a well-studied kinase cascade but few 
phosphatases in the pathway are known. Identification of these phosphatases, especially those that 
counterbalance the activity of the kinases, will provide a better insight into the regulation of this important 
pathway.  C. elegans is an excellent system amenable to genetic manipulations including RNAi. In addition, 
the worm IIS pathway controls several well-defined phenotypes such as life span and dauer formation that 
can be easily quantitated. Therefore, to identify novel phosphatases regulating the IIS pathway, we 
performed a directed RNAi screen using dauer formation as an output. We specifically looked for 
serine/threonine phosphatases, as the majority of phosphorylations in the cell, including the insulin 
signaling pathway, occur on serine or threonine residues (Moorhead, Trinkle-Mulcahy et al. 2007).  
We identified pptr-1 as a top candidate in our screen. This gene encodes a protein that bears 
homology to the mammalian B56 family of PP2A regulatory subunits (Janssens, Longin et al. 2008).  PP2A 
itself is a ubiquitously expressed phosphatase that is involved in multiple cellular processes  including the 
regulation of insulin signaling by direct dephosphorylation of Akt (Andjelkovic, Jakubowicz et al. 1996; 
Resjo, Goransson et al. 2002; Ugi, Imamura et al. 2004). Specificity of PP2A to its various cellular targets is 
achieved by its association with distinct regulatory subunits. Our studies provide a mechanistic insight into 
how the C. elegans PP2A regulatory subunit PPTR-1 modulates insulin signaling by specifically regulating 
AKT-1 phosphorylation and activity in the context of a whole organism. Furthermore, we show that this 
mechanism of regulation is conserved in mammals.  
We identify PPTR-1 as a novel and integral component of the C. elegans IIS pathway. In our model 
(Figure 29), PPTR-1 acts to negatively regulate signals transduced through the IIS pathway, ultimately 
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controlling the activity of the FOXO transcription factor DAF-16. Under low signaling conditions, DAF-16 is 
able to translocate to the nucleus and transactivate or repress its downstream targets. It is well established 
that AKT modulates DAF-16 sub-cellular localization. Thus, the activity of AKT-1, as governed by its 
phosphorylation status, directly translates into the activity of DAF-16. In this study, we show that PPTR-1 
directly interacts with AKT-1 and regulates its activity by modulating its phosphorylation, predominantly at 
the Thr 350 site. Less active AKT-1 results in increased DAF-16 nuclear localization. Indeed, DAF-16 is found 
to be more nuclear throughout the worm when PPTR-1 is overexpressed. As a corollary, knocking down 
pptr-1 by RNAi results in less nuclear DAF-16 as well as reduced expression of DAF-16 target genes such as 
sod-3, hsp-12.6, mtl-1 and sip-1. These genes are known to play a combinatorial role in adaptation to 
various stresses, leading to enhanced dauer formation and increased life span.  Consistent with the 
decreased levels of these important genes, pptr-1 RNAi results in a significant decrease in the dauer 
formation, life span as well as thermotolerance of daf-2(e1370) worms.  In addition, pptr-1 also regulates 
other DAF-16-dependent outputs of the IIS pathway such as fat storage. Thus, we find that normal levels of 
pptr-1 are important under low insulin signaling conditions.  However, pptr-1 RNAi does not affect IIS 
pathway-associated phenotypes in wild type worms. There could be several reasons for this observation. 
Firstly, under normal signaling conditions, AKT-1, AKT-2 as well as SGK-1 are active and negatively regulate 
DAF-16. Therefore, changes in the AKT-1 activity alone brought about by pptr-1 RNAi may not have a 
significant effect on DAF-16-dependent phenotypes.  Secondly, PPTR-1 itself may be negatively regulated 
by the IIS pathway, leading to increased AKT-1 phosphorylation. Along similar lines, in mammals, insulin 
signaling can downregulate the expression and activity of the PP2A catalytic subunit (Srinivasan and Begum 
1994; Hojlund, Poulsen et al. 2002; Ugi, Imamura et al. 2004). Thus, under normal conditions, further down 
regulation of pptr-1 by RNAi may have no effect. We speculate that in C elegans, in response to changing 
environmental cues, PPTR-1 helps to downregulate the insulin signaling pathway to promote DAF-16 
activity, enabling the worm to either enter diapause or enhance its tolerance to stress as adults.  
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In mammals, Akt controls a myriad of secondary signaling cascades that regulate glucose transport, 
protein synthesis, genomic stability, cell survival and gene expression (Toker and Yoeli-Lerner 2006).  
Previous studies have implicated roles for PP2A and PHLPP phosphatases in the negative regulation of Akt 
(Kuo, Huang et al. 2008). The PP2A inhibitor Okadaic acid can increase Akt phosphorylation predominantly 
at Thr 308 and enhance glucose transport in adipocytes (Rondinone, Carvalho et al. 1999). Consistent with 
this, our results show that siRNA knockdown of the PP2A catalytic subunit and more importantly, the B56β 
regulatory subunit results in enhanced Akt phosphorylation at Thr 308 in 3T3-L1 adipocytes. Thus, our 
study points at the remarkable functional conservation of the B56/PPTR-1 regulatory subunit of PP2A in 
regulating AKT phosphorylation between C. elegans and higher mammals. In worms, we also see a modest 
effect on Ser 517 (equivalent to mammalian Ser 473) phosphorylation by PPTR-1 overexpression. However, 
we do not observe a difference in Ser 473 phosphorylation in adipocytes. This difference may be explained 
by the fact that in worms, we are determining the phosphorylation of AKT-1 in the context of a whole 
organism. Additionally, it has been shown in mammals that the pdk dependent phosphorylation (at T308) is 
necessary and also influences the stability of the carboxy terminal phosphorylation at S473. Conversly, 
Okadaic acid (a PP2A inhibitor) increases the phosphorylation of the T308 site predominantly with a 
modest effect on the phosphorylation status of S473 site. These findings are consistent with our 
observation in worms that overexpressing PPTR-1 dramatically decreases the phosphorylation status of 
T350 (homologous to T308 in mammals) while only modestly affecting the S517 (homologous to S473).   
(Toker and Newton 2000; Gao, Furnari et al. 2005). We do not see a role for the PP2A B55 subunit (sur-6) in 
the C. elegans IIS pathway.  However, a recent report using cell culture has implicated the mammalian B55 
in the regulation of AKT (Kuo, Huang et al. 2008). 
In mammals, Akt regulates a myriad of secondary signaling cascades that regulate glucose transport, 
protein synthesis, cell division, genomic stability, glycogen synthesis, cell migration, cell survival and gene 
expression {Toker, 2006 #16933}. Previous studies have implicated roles for PP2A and PHLPP phosphatases 
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in the negative regulation of Akt {Kuo, 2008 #15118}. The B56 family of PP2A regulatory subunits is known 
to regulate several pathways such as Wnt signaling, apoptosis and Erk signaling {Eichhorn, 2008 #14064}. In 
this study, we show that the B56/PPTR-1 regulatory subunit of PP2A specifically modulates Akt 
phosphorylation and hence its activity, thus showing remarkable functional conservation between C. 
elegans and higher mammals. Although we show here that pptr-1  is an integral component of C. elegans 
IIS and lifespan regulation it remains  to be seen if such a function is also conserved in mammals. However 
our findings could probably have significant implications in human diseases. 
Targeting specific B56 isoforms to Akt could potentially be used to downregulate the 
phosphorylation/activity of AKT even when upstream signaling is present. For example, PTEN has been 
shown to be mutated in a large number of cancers almost as frequently as p53 itself. The major 
downstream consequence of PTEN mutations is hyper-phosphorylated AKT, reducing AKT activity in this 
context could have an important therapeutic utility. (Smith U et al, Ann NY Acad Sci, 1999), Sasaoka et al, 
Pharmacol Ther, 2006, Rondinone et al, Diabetologica, 1999). 
Dysregulation of Insulin signaling is also a feature in Diabetes. A major cause of type-II (insulin resistant) 
diabetes has been shown to be desensitization of signaling downstream of IRS. Studies with human 
adipocytes from type II diabetics has shown that Okadaic acid (a PP2A inhibitor), can rescue the insulin 
sensitivity of these adipocytes. Okadaic acid restores insulin sensitivity by its ability to act downstream of 
the IRS proteins directly on Akt1, by inhibiting PP2A activity and indirectly increasing Akt1  phosphorylation 
and glucose transport (Rondinone et al, Diabetologica, 1999). Small molecule inhibitors of specific B56 
isoforms could be potential new therapeutic targets for type-II diabetes.  
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CHAPTER IV 
Materials and Methods 
 
Strains  
All strains were maintained at 15°C using standard C. elegans techniques (Stiernagle 2006). Double mutants 
were made using standard genetic methods as described below. For all RNAi assays, the worms were 
grown for at least two full generations on the RNAi bacteria. 
For making double mutants, daf-2(e1370) males were mated to either akt-1(ok525), akt-2(ok393) 
and sgk-1(ok538) hermaphrodites, respectively. A total of 40 F1 progeny were singled onto individual 
plates and allowed to have progeny at 25 °C. From the F2 progeny on each plate, dauers were selected and 
allowed to recover at 15 °C. The adult worms were singled and transferred to 25 °C and allowed to have 
progeny. The  F3 progeny formed 100% dauers at 25°C, and  parents were tested for akt-1(ok525), akt-
2(ok393) or sgk-1(ok538) deletion by PCR. The primers used for the PCR analysis are listed in Table 11. 
 For making the daf-2(e1370);daf-3(mgDf90) double mutant, daf-2(e1370) males were crossed to 
daf-3(mgDf90) hermaphrodites. The F1 progeny males were selected and mated back to daf-3(mgDf90) 
hermaphrodites. Forty F2 progeny were transferred to individual plates and incubated at 25 °C. After 4-5 
days, parents were selected from plates where the F3 progeny were 100% dauers and the daf-3 deficiency 
was checked by PCR, as described previously (Patterson, Koweek et al. 1997). Dauers were recovered to 
establish the strain. 
For co-localization and immunoprecipitation experiments, pptr-1::mC-flag males were mated to 
myo-3::gfp (Fire, Xu et al. 1998), akt-1::gfp (Sp209) (Paradis and Ruvkun 1998), akt-2::gfp;unc-119(+);unc-
119(ed3), sgk-1::gfp (BR2773; kind gift from Ralf Baumeister) (Hertweck, Gobel et al. 2004) and daf-16::gfp 
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(kind gift from Ruvkun Lab) hermaphrodites, respectively. F1 progeny were selected and subsequently F2 
worms homozygous for both GFP and mCherry were selected under a fluorescence microscope. The 
extrachromosomal lines akt-1::gfp (Sp209) and sgk-1::gfp (BR2777) were integrated into the genome by UV 
irradiation prior to making genetic doubles. 
The daf-2(e1370);daf-16::gfp and daf-2(e1370);Psod-3::gfp(muIs84) strain was made by crossing daf-
2(e1370) males to either daf-16::gfp (kind gift from Ruvkun Lab) or Psod-3::gfp(muIs84) hermaphrodites. 
About 40 F1 animals were transferred to individual plates and allowed to have progeny at 25°C.  From the 
progeny, F2 dauers were selected from each plate and allowed to recover at 15°C. The recovered adult 
worms were then checked for the presence of GFP, and GFP-positive worms were transferred to individual 
plates and incubated at 25 °C. Plates where 100% of the progeny were dauers and GFP positive were 
selected and established as the strain for the assays.  
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Strain  Strain Number  Comment 
daf-2(e1370);akt-1(ok525)  HT1547  
 
daf-2(e1370);akt-2(ok393)  HT1548  
 
daf-2(e1370);sgk-1(ok538)  HT1648  
 
daf-2(e1370);daf-3(mgDf90)  HT1607  Crossed by Sridevi  
akt-1::gfp  HT1632  
Integrated  
SP209 Pakt-1::akt-1::gfp, rol-6 from  
Ruvkun Lab (Paradis and Ruvkun,  
1998)  
akt-2::gfp; unc-119(+); unc-
119 (ed3)  
HT1604  Integrated Line  
sgk-1::gfp  HT1634  
Integrated BR2777 Ex[sgk-1::gfp]  
from Baumeister Lab (Hertweck et al., 
 2004)  
daf-2(e1370);daf-16::gfp  HT1531  
Crossed Pdaf-16a::daf-16::gfp from  
Ruvkun Lab to daf-2(e1370) (Lee et  
al., 2001)  
pptr-1::mC-flag  HT1630  Integrated Line  
akt-1::gfp; pptr-1::mc-flag  HT1644  
 
akt-2::gfp; pptr-1::mc-flag  HT1645  
 
sgk-1::gfp; pptr-1::mc-flag  HT1635  
 
daf-16::gfp; pptr-1::mc-flag  HT1646  
 
myo-3::gfp; pptr-1::mc-flag  HT1647  
Crossed PD4251 to pptr-1 ::mc-flag  
(Fire et al., 1998)  
daf-2(e1370); pptr-1::mc-flag  HT1641  
 
daf-2(e1370) ; Psod-3 ::gfp  HT1643  
Crossed muIs84[pAD76(sod-3::GFP)]  
to daf-2(e1370) (Libina et al., 2003)  
unc-119(+) ; unc-119(ed3)  HT1638  
Extrachromosomal Array Line (made 
 by Eunsoo)  
daf-2(e1370) ; unc-119(+) ; 
unc-119(ed3)  
HT1642  
Extrachromosomal Array Line (made 
 by Eunsoo)  
Table 10 
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Preparation of RNAi plates 
RNAi plates were prepared by supplementing Nematode Growth Media (NGM) media with 100 
µg/ml ampicillin and 1 mM IPTG. After pouring, the plates were kept at room temperature (RT) for 5 days 
to dry. RNAi bacteria were grown overnight at 37°C in LB media supplemented with 100 µg/ml ampicillin 
and 12.5 µg/ml tetracycline. The next day, the cultures were diluted (1:50) in LB containing 100 µg/ml 
ampicillin and grown at 37°C until an OD600 of 0.9. The bacterial pellets were resuspended in 1X PBS 
(phosphate-buffered saline) (for RNAi screen) or PBS with containing 1 mM IPTG for further experiments. 
About 200 µl of the bacterial suspension was seeded onto the RNAi plates. The seeded plates were dried at 
RT for 3 days and stored at 4°C.  
C. elegans assays 
C. elegans assays were modified from previously published methods (Kimura, Tissenbaum et al. 
1997; Henderson and Johnson 2001; Libina, Berman et al. 2003; Oh, Mukhopadhyay et al. 2005; Oh, 
Mukhopadhyay et al. 2006). For detailed description of dauer, life span, fat storage, heat-stress, DAF-
16:GFP translocation and Psod-3::GFP expression assays see below:  
Dauer assays 
For the dauer assays, approximately 5 L4 or young adult worms were transferred to the RNAi 
bacteria and maintained at 15 oC. F2 adult worms were then picked to a fresh RNAi plate and allowed to lay 
eggs. About 120 eggs were picked from these plates onto 2 or 3 fresh plates containing the RNAi bacteria 
and incubated at the indicated temperatures.  The plates were scored for the presence of dauers or non-
dauers after 3.5-4 days, unless indicated otherwise. For assays involving daf-2(e1370);sgk-1(ok538),  the 
strain is slow growing  with a prolonged L1/L2 arrest and only forms dauers on vector RNAi after 7-8 days. 
Similarly, daf-2(e1370);akt-1(ok525) worms grown on vector and pptr-1 RNAi were also scored after 7-8 
days. The pdk-1(sa680) worms have an Egl phenotype. For the pdk-1(sa680) dauer assays, eggs were 
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obtained by hypochlorite treatment (Stiernagle 2006) of gravid adults worms grown on vector, daf-18 and 
pptr-1 RNAi plates grown at 15oC.  
Life span assays 
All life span analyses were performed at 15ºC unless indicated otherwise. For RNAi lifespan worms 
were grown for 2 generations on the RNAi plates, synchronized by picking eggs on to fresh RNAi plates and 
allowed to grow for several days until they became young adults. Approximately 60 young adult worms 
were transferred to each of 3 RNAi plates for every RNAi clone tested. For life span experiments with 
overexpression strains, approximately 60 young adult worms were transferred to 3 fresh OP50 plates for 
every strain tested. Life spans were performed on RNAi plates or OP50 plates overlaid with 5-
fluorodeoxyuridine (FUDR) to a final concentration of 0.1 mg/ml of agar(Hosono, Mitsui et al. 1982).  We 
observed significantly fewer worms bursting at 15ºC by transferring young adult animals rather than L4 
animals to FUDR plates. Worms were then scored as dead or alive by tapping them with a platinum wire 
every 2-3 days. Worms that died from vulval bursting were censored. Statistical analyses for survival were 
conducted using the standard chi-squared-based log rank test.  
Heat stress assays 
 Wild type and daf-2(e1370) animals were maintained on RNAi bacteria at 15ºC. From these plates, 
approximately 30 young adult worms were picked onto the respective RNAi plates. They were shifted to 
20oC for 6 hrs. The plates were then transferred to 37oC and heat stress-induced mortality was determined 
every few hours till all the animals were dead. Statistical analyses for survival were conducted using the 
standard chi-squared-based log rank test. 
Fat staining 
Sudan black staining of stored fat was performed as previously described (Kimura, Tissenbaum et 
al. 1997). Briefly, wild type and daf-2(e1370) worms on RNAi plates were synchronized by picking eggs on 
  97 
 
to fresh RNAi plates and grown until the L3 stage. The worms were then washed off the plates and 
incubated in M9 buffer for 30 minutes on a shaker at RT. After 3 washes with M9 buffer, the worms were 
fixed in 1% paraformaldehyde. The worms were then sequentially dehydrated by washes in 25%, 50% and 
70% ethanol. Saturated Sudan Black (Sigma, USA) solution was prepared fresh in 70% ethanol. The fixed 
worms were incubated overnight in 250uL of Sudan Black solution, on a shaker at RT, mounted on slides 
and visualized using the Zeiss Axioscope 2+ microscope.  
DAF-16::GFP localization assay  
  The daf-2(e1370);daf-16::gfp strain was maintained at 15 oC on vector, daf-18 or pptr-1 RNAi 
plates. About 20-25 L4 or young adults were transferred to fresh RNAi bacteria and the plates were shifted 
to 25 oC for 1hr. The worms were then visualized using Zeiss Axioscope 2+ microscope. Worms were 
classified into four categories based on the extent of DAF-16::GFP nuclear-cytoplasmic distribution.  
+: completely cytoplasmic;  
++: nuclear in some tissues but cytoplasmic in majority of  the tissues;  
+++: cytoplasmic in some tissues but nuclear in majority of  the tissues;  
++++: nuclear localization in all tissues (Hertweck, Gobel et al. 2004) 
Psod-3::GFP expression 
daf-2(e1370);Psod-3::gfp(muIs84) worms were grown at 15oC on RNAi plates as described above. 
About 25-30 L4/young adults were transferred to fresh RNAi plates and shifted to 25oC for 2 hrs. The 
expression of GFP was visualized using Zeiss Axioscope 2+ microscope. Worms were classified into three 
categories based on the intensity of GFP expression.  
High: bright GFP expression seen throughout the worm;  
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Medium: Medium GFP expression in the worm body;  
Low: weak or barely detectable GFP expression in the body.  
GFP expression in the head region does not change dramatically. 
Construction of pSCFTdest 
The pSCFTdest vector was derived from pPD95.75 vector (Fire lab). Briefly, the mcherry gene was 
amplified from the mCherry vector (McNally, Audhya et al. 2006) using primers listed in Table 11. The 
reverse primer added a TEV site with a spacer and a minimal flag tag (Johnson, Liu et al. 2002)to the C-
terminus of mCherry. The amplified product was restriction digested with KpnI and EcoRI and ligated to 
pPD95.75 at KpnI/EcoRI (replacing the gfp gene in the vector) to give pSCFT (CFT-Colocalization Flag tag) 
plasmid.  The R4-R2 gateway cassette from pdestMB14 (Reboul, Vaglio et al. 2003) was PCR-amplified using 
ccdb primers  (Table 11). The amplicon was  restriction digested with KpnI, producing an insert with one 
blunt end and another KpnI-compatible end. pSCFT was then digested with SmaI and KpnI and the blunt 
end/KpnI insert was ligated into the cut vector to make pSCFTdest.  
Transgenic worms 
A 3 kb sequence of the pptr-1 promoter and the pptr-1 ORF were cloned into separate entry vectors 
(Walhout, Temple et al. 2000; Reboul, Vaglio et al. 2003) using Gateway Technology (Invitrogen, USA) and 
confirmed by DNA sequencing. The promoter and ORF were then combined using multi-site Gateway 
cloning into the pSCFTdest vector (Supplemental Methods) to create the pSCFT-pptr-1. An unc-119 
promoter::ORF fusion mini-gene was constructed as described earlier (Maduro and Pilgrim 1995) and 
cloned into pUC-19 vector between EcoRI sites. The unc-119 mini-gene insert was then excised using EcoRI 
restriction digestion, gel-purified, blunt ended with T4 DNA Polymerase (Roche Biochemicals, USA) and 
cloned into pSCFT-pptr-1 (at the filled-in SphI site) giving rise to the pSCFT-pptr-1-unc-119 vector. This 
construct was used in biolistic transformation (Biorad, USA) of unc-119(ed3) mutants (Maduro and Pilgrim 
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1995; Praitis 2006). PPTR-1 over-expression integrated lines were back-crossed four times to wild-type and 
used for further analysis. 
For the akt-2::gfp construct, a 3 kb sequence of the akt-2 promoter was cloned into the corresponding 
entry vector and the akt-2 ORF from the ORFeome were combined using multi-site Gateway technology 
into the R4-R2 destination vector (Reboul, Vaglio et al. 2003) to create akt-2::gfp- unc-119(+) vector. This 
vector was verified by restriction digestion and integrated transgenic lines were obtained by micro-particle 
bombardment (Maduro and Pilgrim 1995; Praitis 2006). 
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seq 1528...1549
gene 1270...1575
gene 270...928
misc_recombR4 38...161
fwd-primer 38...62
C-primer 12...13
filled-in sphI 12...12
 7...11
7 SphI (1)
C-primer 2...11
misc_recombR2 1739...1616
mChr-intron-1 1904...1954
mChr-intron-2 2150...2199
mChr-intron-3 2393...2443
spacer 2609...2617
TEV site 2618...2638
spacer2 2639...2650
minimal Flag 2651...2671
stop 2672...2674
intron5-gfp 2752...2802
Amp 4007...4864
D 3543...3563
ori 5044...5693
pSCFT-dest
6157 bp
backbone frm pSCFT-dest 2151...2197
filled-in sphI 2147...2151
unc-119 12...2146
filled-in sphI 7...11
backbone frm pSCFT-dest 1...11
prom 3kb seq frm A 2198...5305
frm gateway recomb-start 5306...5333
minimal Flag epitope 7895...7915
Spacer2 7883...7894
TEV site 7862...7882
Spacer 7853...7861
misc_feature 7830...7852
mChr-intron-3 7637...7687
mChr-intron-2 7394...7443
mChr-intron-1 7148...7198
mChry ATG 6992...6994
frm gw recomb 6961...6965
12c-actual orf seq (TG to TA) strt - stop... 5334...6960
D 8787...8807
Amp 9251...10108
ori 10288...10937
pptr-1 bomb.
 construct
11401 bp
intron5 7996...8046
STOP 7916...7918
pSCFT Vector map
pSCFT-pptr-1-unc-119 vector map
 
Figure 30 
A 
B 
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C.elegans AKT-1 phospho-specific antibodies: 
Phospho antibodies were prepared and affinity purified by 21st Century Biochemicals (Marlboro, 
MA). Briefly, rabbits were immunized with phospho-peptides (mixture of AKT pT350 PP1 and AKT pT350 
PP2 for T350 and pS517PP1 for S517) and after 6 boosts, the rabbit serum was immunodepleted with a 
peptide column conjugated to non-phosphorylated peptide (AKT T350 NP or AKT S517 NP). Following 
immunodepletion, the sera was affinity purified with Phospho-peptide AKT pT350 PP1 (for T350 site) or 
AKT pS517 PP1 (for S517 site).   
The peptides used were:   
AKT pT350 PP1:  Ac-TS[pT]FCGTPEYK-amide(injected) 
AKT pT350 PP2:  CSYGDKTS[pT]FSGTPEY-amide(injected) 
AKT T350 NP: CSYGDKTSTF[C/S]GTPEY-amide-used for (immunodepletion) 
AKT pS517 PP1: Ac-CSNFTQF[pS]FHNVMGS-amide-conjugated (injected) 
AKT S517 NP:  Ac-CSNFTQFSFHNVMGS-amide-conjugated (immunodepletion) 
C. elegans immunoprecipitation (IP) and western blotting: 
 Transgenic worms were grown in three 100 mm plates seeded with OP50 bacteria at 20 oC. Worms 
were harvested by washing with M9 buffer and pellet collected by centrifugation. The pellet was 
resuspended in 250 µl lysis buffer (20 mM Tris-Cl, 137 mM NaCl, 10% glycerol, 1% Triton X-100, 25 mM β-
glycerophosphate, Protease inhibitor cocktail (Roche Biochemicals, USA), pH 7.4). The worms were 
sonicated with Bioruptor (Diagenode, USA) using maximum power output (1 min sonication, 2 min off-
repeated 10 times). The lysate was cleared by centrifugation and protein content estimated by Bradford 
method. Lysate equivalent to 1.5 mg total protein was pre-cleared with 50 µl of protein-G agarose beads, 
fast flow (Upstate, USA) and then immunoprecipitated overnight at 4 oC using either anti-GFP monoclonal 
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antibody (Sigma, USA) or anti-FLAG M2 gel (Sigma, USA). The following morning, 50 µl protein-G agarose 
beads, fast flow were added to the GFP IP to capture the immune complex. The agarose beads were then 
washed 5 times with lysis buffer. Following this step, the beads were boiled in Laemelli’s buffer.  
For western blot analysis, immunoprecipitated protein samples was resolved on a 10% SDS-PAGE 
and transferred to nitrocellulose membranes. Membranes were blocked in TBST (Tris Buffered Saline 
containing 0.05% Tween 20, ph 7.4) containing 5% non-fat milk at RT for 1 hour.  Membranes were then 
washed with TBST and incubated overnight with 1:1000 dilutions of antibodies in TBST containing 5% non-
fat milk 4 ºC.  Membranes were washed 3 times with TBST and then incubated with TBST containing 5% 
non-fat milk containing a 1:10,000 dilution of the secondary antibody. Antibodies used for western were:  
Living Color DsRed antibody (Clontech, USA; Catalog no. 632496) 
Living Color Rabbit polyclonal GFP antibody (BD Biosciences, USA; Catalog no. 632460) 
Monoclonal mAb 3e6 GFP antibody (Invitrogen, USA; Catalog no. A11120)  
Anti-FLAG M2 Affinity Gel (Sigma, USA; Catalog no. A2220). 
C. elegans phospho-AKT western blotting: 
Transgenic worms were grown at 20 oC in 3-4 large (100 mm) plates seeded with OP50. Worms 
were collected by washing with 1 X PBS and the pellet was then immediately frozen in dry ice. Around 500 
µl lysis buffer, supplemented by Sigma Phosphatase inhibitor cocktails I and II (50x) and Protease inhibitor 
cocktail (Roche Biochemicals, USA) was added to the pellet and sonicated using a Misonix (3000) sonicator 
(Misonix, USA; power output set at 4, 3 pulses of 10 secs each with 1 min interval between pulses). The 
lysates were clarified by centrifugation at 13000 rpm for 10 mins at 4oC and the protein content estimated 
by Quick Bradford (Pierce). About 3.5 µg of anti-GFP monoclonal antibody (3E6, Invitrogen USA) was used 
for each IP from lysates containing 1.7 mg protein in a volume of 1ml. IPs were performed overnight  at 4oC 
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and antibody-protein complexes were captured using 50 µl of protein-G agarose beads, fast flow (Upstate, 
USA) for 2 hrs at 4oC. The pellets were washed 3 times with lysis buffer supplemented by protease and 
phosphatase inhibitors and boiled in Laemelli’s buffer. The IP samples were then resolved on a 10% SDS-
PAGE, western blotted and analyzed with phospho-specific antibodies (Supplemental Materials and 
Methods).  
Mammalian cell culture and phospho-Akt Western blotting 
3T3-L1 adipocytes were cultured and differentiated as previously described (Tesz, Guilherme et al. 
2007).   For siRNA transfections, cells from 4 days post-induction of adipocyte differentiation were used as 
previously described (Tang, Guilherme et al. 2006).  Cells were stimulated with increasing concentrations of 
insulin and isolated proteins were analyzed by Western blotting  Detailed procedure is described in 
Supplemental Materials and Methods.  
Cell culture and siRNA transfection: 
3T3-L1 adipocytes were cultured and differentiated in complete Dulbecco’s modified Eagle’s 
medium (10% fetal bovine serum, 50 units/ml penicillin, and 50 g/ml streptomycin) as previously described 
(Tesz, Guilherme et al. 2007).   For siRNA transfections, cells from 4 days post-induction of adipocyte 
differentiation were used as previously described (Tang, Guilherme et al. 2006). Briefly, 1.125 x 106 cells 
were electroporated using 6 nmol of siRNA and then plated in 5 wells of a 12-well plate. Cells were 
recovered in complete DMEM and were cultured for 48 h after the transfection prior to the experiments.   
Insulin stimulation and phospho-Akt western blotting 
3T3-L1 adipocytes transfected with siRNA were serum-starved for 18 hours.  Cells were stimulated 
with increasing concentrations of insulin for a period of 30 minutes.  Following insulin stimulation, the cells 
were washed with ice-cold PBS and harvested on ice as described previously (Tesz, Guilherme et al. 2007).  
Protein samples were resolved on 8% SDS-PAGE and transferred to a nitrocellulose (NC) membrane as 
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mentioned above. Antibodies used were Phospho-Akt Ser 473 (Cell Signaling, USA; Catalog no. 9271), 
Phospho-Akt Thr 308 (Cell Signaling, USA; Catalog no. 9275), total Akt antibody (Cell Signaling, USA; Catalog 
no. 9272). Secondary antibody incubation was performed as above in 1% BSA.  Changes in the 
phosphorylation of Akt pSer 473 and pThr 308 were quantified through densitometry using NIH ImageJ and 
normalized for loading against the non-phosphorylated total Akt levels.   
RNA isolation and real-time PCR 
RNA was isolated using Trizol (Invitrogen, USA).  Briefly, worms grown on vector, daf-16, daf-18 or 
pptr-1 RNAi were washed off the plates using M9 buffer. Next, 0.3 ml of TRIzol reagent was added and 
vortexed vigorously. The RNA was then purified by phenol:chloroform:isoamylalcohol extraction and 
ethanol precipitation. The concentration and the purity of the RNA were determined by measuring the 
absorbance at 260/280 nm. To further determine the quality of the RNA, the quality of the ribosomal 28 S 
and 18 S was visually inspected on an agarose gel.  cDNA was synthesized using 2 ug of RNA and the 
SuperScript cDNA synthesis kit (Invitrogen, USA).  
DAPI Staining 
   pptr-1::mC-flag worms were washed off an OP50 plate with PBS and washed thrice by briefly 
spinning the worms at 3000rpm for 1 minute. The supernatant was collected and 500uL of 3% 
Formaldehyde (diluted with potassium phosphate buffer, KH2PO4) was added to the worm pellet. The 
samples were fixed for 15-20 mins with gentle shaking, and 500uL of PBS-Tween (0.1%) was added and 
gently mixed. The samples were then spun at 3000rpm for 1 minute and washed twice with PBS-Tween and 
the supernatant was removed. 2uL of DAPI (1mg/mL, Sigma D9542) added to 500uL of PBS and the samples 
were incubated in this solution for 15-20 minutes before mounting. 
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Table 11 
Gene Amplified Used for Sequence (5'-3') 
akt-1 Detecting akt-1 deletion AGAGCGTCTATGATTAGTATTG 
akt-1 Detecting akt-1 deletion TACTTTCTGTGGAACTCCGGAG 
akt-1 Detecting akt-1 deletion AGTTTCTGACTGCACATTTGGC 
akt-2 Detecting akt-2 deletion       AGTACACAGAGTGTGATAATGC 
akt-2 Detecting akt-2 deletion GCAAACTCCATCACAAAACAG  
akt-2 Detecting akt-2 deletion CACGTAGTATGACGCAAATTG 
sgk-1 Detecting sgk-1 deletion TCAGGCTTCAAATCTCTGGAA  
sgk-1 Detecting sgk-1 deletion AAACAGGCAAATACGGCATC 
sgk-1 Detecting sgk-1 deletion CACGTCATGGCAGAAAGAAA 
daf-3 Detecting daf-3 deletion CTGGCAGTCACTAACACACG 
daf-3 Detecting daf-3 deletion ACCCTCATGCCTACTGTCAG 
mChry(fw-KpnI) mCherry  cloning  AGCTCG GGTACC G ATGGTCTCAAAGGGTGAAGAAG 
mcherry(Rv-
EcoRI-CF-tag):  
mCherry  cloning  TACGAATGAATTCTTAATCATCGTCCTTATAGTCCATTCCGC
TAGCTCCACCCTGAAAATACAAATTCTCTCCAGCTCCCTTAT
ACAATTCATCCATGCCAC 
ccdb Ccdb amplification CAA CTT TGT ATA GAA AAG TTG AAC G 
ccdb  Ccdb amplification ATAATGGTACCTCAACTTTGTACAAGAAAGTTGAACGA 
unc-119 (prom) unc-119 amplifcation TGTTTTGTGCCAAGCTTCAG  
unc-119 (prom)  unc-119 amplification AGTTCCGTGTGCTCTTGCTC  
unc-119(cDNA)  unc-119 amplification GGACGACCCCCATTAATTTT  
unc-119(cDNA)  unc-119 amplification ATCTGA AAGCTT TGAAAAATCATTTATTGGGATTTG  
sod-3 RTPCR GGAGTTCTCGCCGTCCG 
sod-3 RTPCR GTCGAATGGGAGATCTGGGAG 
mtl-1 RTPCR AGTGTGACTGCAAAAACAAGCAA 
mtl-1 RTPCR TCCACTGCATTCACATTTGTCTC 
hsp-12.6 RTPCR GGGATTGGCCACTTCAAAAG 
hsp-12.6 RTPCR CGTCGTCGAGGACATTGACA 
sip-1 RTPCR AAGAGATCGTTCACTCGCCAG 
sip-1 RTPCR AGCCAAGTCGACGTCCTTTG 
act-1 RTPCR CTCTTGCC CCATCAACCATG   
act-1 RTPCR CTTGCTTGGAGATCCACATC   
PP2Acα  RTPCR  ATGGACGAGAAGTTGTTCACC 
PP2Acα  RTPCR  CAGTGACTGGACATCGAACCT 
PP2Acβ  RTPCR  ATGAGTGCCTACGGAAGTATGG  
PP2Acβ  RTPCR  CAGGGCTCTTATGTGGTCCAG  
B56α  RTPCR  ATTGAAGAGCCGCTTTTTAAGCA  
B56α  RTPCR  TGAGGGTTTTCAGCACATTGT  
B56β  RTPCR  GGGCCTACATCCGCAAACA  
B56β  RTPCR  GGATCAGGACTCGAACCAGG  
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APPENDIX 
PPTR-2, a daf-16 phosphatase? 
 
While characterizing pptr-1, we found that the RNAi of the other B56 subunit – pptr-2  also had a slight 
effect on dauer formation (although not reaching statistical significance) but had stronger effects on rate of 
growth and brood size at 15oC and 20oC. Importantly, the worms that had escaped dauer stage were far 
more advanced in their growth stages compared to Vector RNAi plates. These observations suggested that 
pptr-2 might also have a role to play in the IIS pathway regulation like pptr-1. Mass RNAi screens have 
shown that the pptr-1 and pptr-2 are synthetic lethal (Tischler, Lehner et al. 2006). We observed similar 
lethality upon RNAi knockdown of pptr-1 in a pptr-2 mutant. These observations suggested that pptr-2 acts 
redundantly with pptr-1 for an essential pathway and might also have a similar effect in IIS pathway.  
Preliminary experiments were done to determine the role of pptr-2 in regulating IIS phenotypes in 
C. elegans. pptr-2 had weaker dauer suppression effects but consistently showed mild dauer suppression 
and clear growth enhancement. We found that pptr-2 RNAi suppressed daf-2(e1370) (Figure 1), daf-2;akt-
2(ok393) (Figure 2), pdk-1(sa680) (Figure 3 and Table I), daf-2(e1370);akt-1(ok525)(Figure 4, 5), daf-2;sgk-
1(ok538) (Figure 6) growth and dauer  phenotypes to varying levels. Figure 1 shows acceleration of growth 
in daf-2(e1370) worms in pptr-2 RNAi compared to vector.  pptr-2 RNAi cannot suppress dauer formation of 
pdk-1(sa680) at 25o C (Figure 3B, Table IB) (100% dauers in vector and pptr-2) and daf-2;akt-1(ok525) at 20 
oC (Figure 4) but pptr-2 RNAi suppressed dauer formation significantly in pdk-1(sa680) at 15 oC (Figure 3A) 
and of daf-2(e1370);akt-1(ok525) double at 19.2 oC (Figure 5). In contrast to pptr-1 RNAi which was unable 
to suppress dauer formation of daf-2(e1370);akt-1(ok525) mutant even at this lower temperature(Figure 
5).  
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We next checked if pptr-2 RNAi has an effect on daf-2(e1370) lifespan. Significantly, pptr-2 RNAi decreased 
daf-2 lifespan from 33.6±0.9 in vector RNAi to 26.7±0.9 (Figure 8). 
 Surprisingly, pptr-2 RNAi extended the lifespan of N2 worms significantly from 22.1±0.4 to 27.8±0.6. pptr-1 
RNAi did not affect N2 lifespan (Figure 7). We repeated the RNAi experiment in a daf-16(mgdf50) mutant 
and found that pptr-2 RNAi did not affect the lifespan of daf-16 mutant (Figure 9). This indicated the pptr-2 
was acting upstream or at the level of daf-16. The opposite effects on daf-2 and N2 lifespan suggested an 
extra level of complexity in regulation of pptr-2. pptr-2 and pptr-1 belong to the B56 regulatory subunit 
family and they are known to be synthetically lethal in large scale RNAi screens.  We therefore checked the 
levels of pptr-2 in a pptr-1 knockdown. Interestingly pptr-2 levels went up by 3.5 fold upon pptr-1 
knockdown  at 20oC but not at 15oC. Table 2A, 2B.  It is possible that a similar regulation exists upon pptr-2 
knockdown. pptr-2 knockdown could result in pptr-1 upregulation in-turn leading to increased inactivation 
of AKT-1 and increased DAF-16 activity eventually resulting in an lifespan extension in a N2 background. But 
in a daf-16 mutant background such an effect is not seen. 
 However, pptr-2 knockdown also reduces daf-2(e1370) lifespan and can suppress dauer formation 
of all the mutants studied albeit at a lower efficiency. This indicates that pptr-2 is an integral part of insulin 
signaling pathway and normal activity is required for daf-2 mediated lifespan extension. The epistasis 
places pptr-2 downstream of akt-1/2 and sgk-1 and potentially might act on daf-16. However, it is also 
possible that pptr-2 acts on a different substrate or on multiple kinases for example sgk-1 and akt-2. 
Interestingly, in-silico analysis of pptr-2 interactors with the tools of Zhong et al, brings up a forkhead 
containing protein in C. elegans. More work is needed to dissect out the importance of pptr-2 in the C. 
elegans IIS pathway. 
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Figure 1 
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Table 1 
 
 
 
pdk-1(sa680) 15 oC 
pdk 15C L1±Stdev dauers±Stdev L3±Stdev L4±Stdev YA±Stdev GA±Stdev 
Vector 13.9±9.2% 40.3±2.8% 28.5±0.4% 7.9±3.9% 5.1±1.8% 4.3±6% 
pptr-1 0±0% 0±0% 6.1±3.5% 5.7±2.2% 15.7±6% 72.5±11.7% 
pptr-2 0±0% 6.3±3.9% 26±2.4% 12.5±0.2% 22.6±7.2% 32.7±0.7% 
F47B8.3 0±0% 51.7±0% 30±0.7% 10.2±1.1% 6.1±2.7% 1.9±0.8% 
daf-16 0±0% 0±0% 3±0.5% 0±0% 9.5±5.5% 87.5±5% 
 
 
 
 
pdk-1(sa680) 25oC 
 L1±Stdev dauers±Stdev L3±Stdev L4±Stdev YA±Stdev GA±Stdev 
Vector 2.4±3.4% 97.6±3.4% 0±0% 0±0% 0±0% 0±0% 
pptr-1 6.1±0.3% 57.4±2.7% 3.2±2.2% 0.4±0.6% 32.8±0.8% 0±0% 
pptr-2 2.6±0.4% 97.4±0.4% 0±0% 0±0% 0±0% 0±0% 
F47B8.3 5.7±3.4% 94.3±3.4% 0±0% 0±0% 0±0% 0±0% 
daf-16 0±0% 0±0% 0±0% 0±0% 0±0% 100±0% 
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daf-2(e1370);akt
daf-2(e1370);akt
 L1%±stdev dauers%±stdev
Vector 5±5% 9.3±9.3%
daf-18 0 1.3±1.3%
pptr-1 3.1±3.1% 4.3±4.3%
pptr-2 8.7±8.7% 9.3±9.3%
F47B8.3 3.5±3.5% 0.5±0.5%
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Figure 9 
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transcript levels  at 15oC (fold change) 
RNAi pptr-1 pptr-2 sod-3 
pptr-1 0.3 1.0 0.6 
daf-18 1.3 1.4 0.4 
daf-16 1.2 1.5 0.4 
transcript levels  20oC(fold change) 
RNAi pptr-1 pptr-2 sod-3 
pptr-1 0.5 3.5 0.7 
daf-18 1.6 2.2 0.5 
daf-16 1.6 1.8 0.2 
transcript levels  compared between 
15oC and 20oC(fold change) 
RNAi pptr-1 pptr-2 sod-3 
Vector 0.6 0.6 2.2 
pptr-1 1.0 3.8 2.5 
daf-18 0.8 0.9 2.6 
daf-16 0.8 0.7 1.4 
A 
B 
C 
A) daf-2 (e1370) worms subjected to RNAi of pptr-1, daf-18 and daf-16 
grown at 15oC 
B) daf-2 (e1370) worms subjected to RNAi of pptr-1, daf-18 and daf-16 
grown at 20oC shows upregulation of pptr-2 by 3.5 fold upon pptr-1 
RNAi  
C) daf-2 (e1370) worms were subjected to RNAi of Vector, pptr-1, daf-
18 and daf-16  and transcript levels of pptr-1, pptr-2 and sod-3 
compared between 15oC and 20oC 
Table 2 
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